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Abstract  
 
Tissue engineering is a field which has shown great promise in developing cell-based 
products to replace damaged or diseased tissue in the body.  However, current tissue culture 
techniques lack the ability to position cells into a desired three-dimensional shape without an 
exogenous scaffold.  The goal of the project was to design a bioreactor which has the capability 
to position cells in three dimensions and support tissue growth.  Collagen-coated agarose beads 
seeded with rat aortic smooth muscle cells (RASMCs) were introduced into the bioreactor and 
positioned on a magnetic rod, forming a tube.  The magnetic rod, encapsulated by a dialysis tube, 
contains a flow of fresh media, allowing nutrients to diffuse throughout the cultured tissue.  A 
secondary flow of media external to the rod allows for bead seeding and additional nutrient flow.  
Fluid flow, cell-bead attachment, and bead seeding design aspects were validated and a proof-of-
concept was tested with cells. The device was able to run without contamination and met the 
objectives of cell positioning, continuous nutrient flow, and ease of sampling. 
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Chapter 1 Introduction  
The field of tissue engineering has shown to be promising in harnessing the proliferative 
capacity of cells to regenerate human tissue.  Progress has been made in developing techniques 
to culture cells under conditions which resemble those found in vivo. Bioreactors can aid in 
replicating in vivo conditions by providing high rates of nutrient transport and mechanical 
conditioning to a tissue culture.  While culture conditions are important in guiding cell 
differentiation and proliferation, the tissue also needs to form into the required geometry.  There 
is still no ideal method to seed and position high densities of cells into a specified three-
dimensional (3-D) shape. Additionally, there are limited methods to seed layers of multiple cell 
types so that multi-layered tissues such as blood vessels can be efficiently recreated. The aim of 
this project was to develop a bioreactor which can position cells into a 3-D construct and provide 
an optimal environment for the cells to form a tissue. 
Traditional cell culture involves growing cells in a flask or tissue culture dish where the 
cells bind to a two-dimensional (2-D) surface.  This technique produces conditions which do not 
represent an in vivo environment, possibly resulting in a loss or change in cell differentiation and 
function (Elsdale 1972).  Frequent media changes are necessary in static culture systems while 
limited diffusion of nutrients causes hypoxia within high-density tissue cultures (Darling 2005). 
Bioreactors have emerged as tools to overcome the diffusion limitations of static culture and 
more closely replicate in vivo conditions.  Bioreactors culture cells in dynamic culture 
conditions, where flowing media improves nutrient diffusion.  
Bioreactors typically require a natural or synthetic scaffold to deliver the cells and define 
tissue geometry.  Scaffolds have a number of issues including biocompatibility (Williams 2008), 
control of degradation rate (Dahl et al. 2007), cell migration into scaffolds even as small as 1.2 
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mm thick (Zhao and Ma 2005), mechanical mismatch with surrounding tissue (Weinberg and 
Bell 1986), and alteration of cell phenotype (Higgins, Solan and Niklason 2003).  This is 
particularly harmful for tissue engineered blood vessels which need to withstand high 
mechanical loads and recreate native morphology to prevent blood clotting and mechanical 
mismatch. Thus, the recreation of blood vessels has been the topic of a significant amount of 
scaffold-free tissue engineering research (L'Heureux et al. 1998, Ito et al. 2005, L'Heureux et al. 
2006, Norotte et al. 2009).   
Scaffold-free tissue engineered blood vessels have yielded promising results, but are 
limited by the length of time and number manipulations involved in the manufacturing process.  
For example, vascular grafts produced by CytoGraft, are made by culturing sheets of a patient’s 
cells; manually rolling the cell sheets together, and then culturing the tubular product (Mcallister 
and L'heureux 1999).  This process takes approximately three months to complete (Mcallister 
and L'heureux 1999), and could potentially be simplified if the cells could be positioned into a 
tube without multiple culture steps.  The tissue manipulation also incorporates additional room 
for error.  For the true recreation of a blood vessel, it is also important to mimic its three layers of 
different cell types: endothelial cells (tunica intima), smooth muscle cells (tunica media), and 
fibroblasts (tunica adventitia).  The CytoGraft blood vessel is composed of only of fibroblasts 
and endothelial cells (L'Heureux et al. 2006). 
Therefore, there is still the unmet need for a system which can position a high density of 
cells into a three-dimensional tissue and provide adequate nutrient transport for tissue growth.  
The goal of this project was to develop a bioreactor which harnesses magnetic fields to 
manipulate cell position and facilitate the formation of a tubular tissue construct. The device 
should maintain proper conditions for optimal cell growth and enable fabrication of tissues 
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composed of multiple cell types. The product may be used to generate replacements for diseased 
or damaged tissues (blood vessels), to study tissue function, or for bioprocessing.  
The design team followed a five-stage prescriptive model for design, as directed by 
Engineering Design: A Project Based Introduction by Clive I. Dym and Patrick Little. The first 
stage was to meet with the clients to identify objectives and clarify the client statement. This 
allowed for clarification of the problem and a formulation of conceptual and preliminary designs. 
Engineering design tools were utilized to assess key aspects and develop a final design.  The 
principles behind the design were validated and a proof-of-concept prototype was built and 
tested. 
The client statement indicated the need for a bioreactor that will grow a 3-D tissue and 
mimic an in vivo environment for that tissue.  Prior to entering the design stage the team wanted 
to get a better understanding of the problem and client statement. This was done by researching 
topics that were related to the client statement to define the project in terms of previous research.  
In order to better understand what has already been developed, a patent search and literature 
review were conducted and is detailed in Chapter Two.  Based on the background research and 
meetings with the client, the design team was able to establish objectives that indicated a need 
for 3-D cell positioning, continuous nutrient support, seeding of multiple cell types, ease of 
manufacturing and sterile sampling. Constraints included a budget of $468, a deadline of April 
22nd, 2010, and size (fits in an incubator).  The objectives and constraints were used to revise and 
clarify the client statement.  A more detailed discussion of the design specifications, objectives, 
constraints, and functions, is described in Chapter Three.  
Based on the design parameters discussed in Chapter Three, several conceptual designs 
were generated and are detailed in Chapter Four.  Each part of the design including the flow 
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system, seeding methods, and magnetic array were then evaluated in a design matrix (as shown 
in Appendix C). A preliminary design was developed and validation experiments were 
performed to verify the principles behind the design as detailed in Chapter 5.  In Chapter Six, the 
validation experiments are discussed along with environmental, political, and economical factors 
of the design.  A proof-of-concept prototype was manufactured and the device’s capabilities 
were verified in meeting the client’s objectives. The final design verification experiments, as 
well as the fabrication, were documented and are detailed in Chapter Seven. In Chapter Eight, 
recommendations for future work on the design were made based on the results and conclusions 
of the validation experiments, so that future groups would be able to make improvements to the 
design.  Throughout the design process, the team attended regular meetings and maintained 
contact with the client in order to receive feedback and update the client on the status of the 
device. In order to complete the final design stage, the team submitted all documentation to the 
client. 
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Chapter 2 Literature Review 
 
Cell culture has long been vital to the advancement of biological sciences. The ability to 
grow and manipulate cells in vitro opens innumerable possibilities for the discovery of 
treatments and cures to various diseases, understanding of life on a cellular level, and creation of 
living tissues (Moore and Ulrich 1965, DiCosmo and Misawa 1995, Goubko and Cao 2009).  
The ability to create a 3-D functional tissue from cultured cells has applications not only in tissue 
engineering, but also in understanding the human body and its complex functions (Griffith and 
Swartz 2006).  In order to fully understand the benefits of 3-D cell culture, it is important to first 
explain the differences between 2-D and 3-D cell culture methods and what advantages 3-D cell 
culture offers. 
2.1 Differences Between 2-D and 3-D Cell Culture  
 Both 2-D and 3-D cell culture techniques are used for tissue engineering (Griffith and 
Swartz 2006). Though each technique has its own benefits, it is important to highlight the 
differences between them and the limitations each method has. The most notable difference 
between 2-D and 3-D cell culture is the variation in morphology and cellular function that each 
method produces (Griffith and Swartz 2006). In vivo, all tissue grows and functions in an 
environment which allows for cell-cell interactions to occur. These interactions have been shown 
to have an effect on how a cell’s function and morphology in a variety of cell types, including 
hepatic cells, corneal and lung epithelial cells, and keratinocytes (Papini et al. 2005, Soletti et al. 
2006, Sakai et al. 2010).  When grown in on a 2-D culture dish were cell-cell interactions are 
limited, cells have been shown to have function changes such as lower protein production and 
altered morphology (Griffith and Swartz 2006). These differences are vital to creating cultures 
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that behave and function like in vivo tissue and allow a better understanding of how cells 
function, grow, and interact (Toh et al. 2007).  
Due to the increased resemblance to in vivo tissue, cell cultures grown in three 
dimensions have an enormous value in tissue-engineered organs and research models (Abbott 
2003). 3-D cell culture allows for function and morphology more closely related to cells grown 
in vivo and allows for cells to grow in a thickness more like human tissue (Lichtenberg et al. 
2005, Griffith and Swartz 2006). This thickness helps to make cell-cell interactions more 
effective and provides an environment closer to that of in vivo growing cells, though this also 
presents issues with nutrient and gas diffusion (Lichtenberg et al. 2005).  
2.2 Limitations of Three-Dimensional Cell Culture 
 
Difficulties have arisen with developing 3-D cell culture systems including the inability 
to seed a large volume of cells, feed dense tissue cultures, maintaining cell function, and cell 
survival. Though current methods prove the importance of 3-D cell culture in producing cells 
that more accurately resemble in vivo function and morphology, these limitations must be 
considered and addressed in order to develop a more successful method for 3-D cell culture and 
the development of a functional tissue. 
The ability to seed a large volume of cells is vital for successful tissue culture (Toh et al. 
2007). Many cell culture techniques are unable to seed large volumes of cells, as well as control 
positioning and provide structural support in the beginning of tissue formation (Martin, Wendt 
and Heberer 2004). This limits the ability to form shapes that may be vital in final function of a 
cultured tissue, such as with blood vessels (Conejo et al. 2007).  
Another complication is the diffusion of media, gas, and nutrients through a 3-D culture 
(Lichtenberg et al. 2005).  Since growing cells in three dimensions necessitates an increased 
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thickness of tissue, it is also important to consider the diffusion capabilities of the culture 
(Griffith and Swartz 2006, Goubko and Cao 2009).  Depending on the thickness of the tissue, it 
may be difficult to transport nutrients through the entire cell culture, causing cells in the center of 
a tissue or farthest away from media flow to die (Lichtenberg et al. 2005). Studies have shown 
difficulties with diffusion of nutrients and media through a cell culture with a thickness greater 
than 2 mm (Griffith et al. 2005). Despite these limitations, 3-D cell culture is being used to 
develop cells more like those found in vivo for various testing and tissue engineering projects 
and is still being perfected (Abbott 2003). One important tissue engineering area that is taking 
advantage of 3-D cell culture techniques is research involving vascular tissue and tissue 
engineered blood vessels (Rhim and Niklason 2006).  
2.3 Tissue Engineered Blood Vessels 
 
In the creation of tissue engineered blood vessels, it is necessary to first understand in 
vivo structure, function, and conditions so that these aspects can be replicated. Vascular tissue is 
comprised of three main layers which gives its function and structure. The outer most layer, 
known as the tunica adventitia, is composed of fibroblasts which provide mechanical strength 
(Fox 2009). The middle layer of the blood vessel is called the tunica media and is the thickest 
layer.  It is comprised of smooth muscle cells in a collagen and elastin matrix.  The tunica media 
gives the blood vessel the ability to contract (Fox 2009).  Smooth muscle cells are oriented in the 
same direction within the tissue to give the tissue uniform properties and elasticity (Bolton et al. 
2004). The inner layer, referred to as the tunica intima, is made of endothelial cells which have 
direct contact with blood flow and prevents clotting within the blood vessel (Conejo et al. 2007, 
Fox 2009).  
16 
 
Due to the various conditions that a vascular tissue must undergo, it is important to 
understand their mechanical limits as well. Though the pressures and mechanical wear a blood 
vessel is exposed to varies depending on size and location within the body, the majority of 
vascular tissues used in treatments like coronary artery bypass surgery and arteriosclerosis 
involve the use of the saphenous vein or mammary artery (Canver 1995). These burst pressures 
of these vessels vary from 1599 ± 877 mmHg in the saphenous vein to 3196 ± 1264 mmHg in 
the internal mammary artery (Konig et al. 2009). It would therefore be important for tissue 
engineered blood vessels to fall within this range in order to provide adequate mechanical 
support for blood flow. 
 Tissue engineered blood vessels are needed to treat a variety of diseases and traumas. For 
example, arteriosclerosis is blockages or clots of plaque within an artery that can restrict blood 
flow (Zhang et al. 2007).  Though arteriosclerosis is most prevalent in men over the age of 50, it 
can also affect young adults and woman with cholesterol conditions or poor dietary habits 
(Association 2010). In 2004 in the United States alone, approximately 1.2 million people were 
hospitalized due to arteriosclerosis. Expenses for treatment and hospital stays were estimated to 
be around $44 billion (American Heart Association 2010). There are some pharmaceutical 
treatments that may help clear this plaque but surgery is often the most effective option if the 
blockage is too large (Yang, Bei and Wang 2002). In 2006, approximately 500,000 coronary 
bypass surgeries were performed and that number is expected to grow as the population over 50 
increases dramatically of the next few years (American Heart Association 2010).  
Vessel replacement typically involves taking vascular tissue from a secondary site within 
the patient in order to avoid donor-rejection complications, but this leaves the patient with a 
secondary wound site and possible damage due to the removal of vascular tissue in the secondary 
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site (Hoenig et al. 2005).  This surgery is also not possible on patients who have had a prior 
transplant and do not have suitable vessels.  The application of a tissue engineered blood vessel 
could also go far beyond coronary artery bypass surgery to help victims of severe trauma to 
vascular tissue (Stanec et al. 1997).  The study of tissue engineered blood vessels continues to 
grow with a better understanding of blood vessel disease, infection, and failure (Spiel, Gilbert 
and Jilma 2008, Rohner et al. 2003, Ong et al. 2008). 
With the availability of a tissue engineered blood vessel, patients would no longer need to 
endure a secondary surgical site and treatments may be more readily available (Germain, Remy-
Zolghadri and Auger 2000). Even though the societal need is tremendous, there are still many 
limitations to creating a successful vascular tissue, including possible calcification, infection, or 
inability for the tissue to grow if implanted in a child or young adult (Rhim and Niklason 2006). 
There are several techniques that are currently being tested and used in order to meet the need for 
a tissue engineered blood vessels.  
2.4 Current Techniques for Tissue Engineered Blood Vessels 
  
 Despite the issues surrounding 3-D cell culture, various effective techniques have been 
developed specifically to create tissue engineered blood vessels. Among the various ways blood 
vessels are created, the majority of methods fall into two distinct categories: scaffold and 
scaffold-free tissue engineered vascular tissue (Kim et al. 1998, Rhim and Niklason 2006, Ong et 
al. 2008, ).   
Scaffolds 
Polymer scaffolds provide structural support as cells grow and allow for cells to form a 
tissue of a defined shaped (Baker and Southgate 2008). Generally, scaffolds are porous structures 
that are biocompatible and allow for cell growth in and around the structure (Nair and Laurencin 
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2007). As cells grow and begin forming their own extracellular matrix (ECM), some scaffolds 
are able to degrade over time leaving the tissue fully intact once it no longer needs the support of 
the scaffold (Krenning et al. 2008).  Scaffolds can also be tailor-made using various 
combinations of polymer materials to control degradation rate, size, properties and cell 
interactions and cost (Nair and Laurencin 2007).  In the specific case of blood vessels, smooth 
muscle cells can be seeded onto a polymer scaffold in order to allow for positioning as well as 
structural support as the tissue begins to form and then degrade over time, leaving a formation of 
smooth muscle cells in the desired shape and diameter size (Kim et al. 1998, Vaz et al. 2005, 
Krenning et al. 2008). 
One such example of a vascular tissue being created from a scaffold came from a group 
who was able to use biodegradable poly(ester urethane) urea (PEUU) scaffolds to seed smooth 
muscle cells (Nieponice et al. 2008). Using a specialized vacuum seeding technique, the seeded 
the scaffolds with smooth muscle cells. After 7 days of culture, vascular grafts with 
2127±900 mmHg burst pressures were formed. The group saw limitations in the inability to seed 
endothelial cells into the scaffold as well as limitations with nutrient transfer in the spinner flask 
culture system (Nieponice et al. 2008).  Another group used a co-polymer Poly(ε-caprolactone) 
(PCL) and collagen scaffold to create a vascular tissue by processing the two materials into a 
thread-like consistency and combining them together through a process known as 
electrospinning (Ju et al. 2010). Electrospinning is a process that spins polymer threads together 
in order to create a scaffold with control of pore size through variations in the velocity at which 
the scaffold is spun as well as the thickness of the threads used (Matthews et al. 2002). The 
group was able to create a mechanically strong scaffold to support the cells and was able to seed 
19 
 
smooth muscle cells into the scaffold, though no vascular tissue was ultimately formed. They 
hypothesized that this was due to a limited ability to seed cells into the scaffold (Ju et al. 2010).  
Scaffold techniques often have issues with seeding a high density of cells as well as non-
uniform cell distribution, which is important for proper tissue formation (Martin et al. 2004).  
Other issues with using scaffolds for blood vessel culture are that acidic or toxic scaffold 
degradation byproducts and incomplete scaffold degradation which can affect the structural 
integrity and shape of the final product (Dutta and Dutta 2009, Norotte et al. 2009). Though 
scaffolds provide strong mechanical support initially, the ability to seed limited number of cells 
as well as various other issues with degradation make this specific technique limited in its use for 
tissue engineered blood vessels. 
Cell Sheets 
Cell sheets are a technology that utilizes the natural ECM of cells in order to form a 
scaffold to support cellular growth while avoiding the negative side effects of exogenous 
scaffolds (Yang et al. 2007). Sheets are produced through culturing cells such as fibroblasts or 
endothelial cells that produce ECM rapidly in a two-dimensional culture.  The sheets are 
harvested, the scaffold is decellularized and reseeded with the cell type of choice (Gao et al. 
2009). Though chemicals originally used to decellularize the scaffold were found to weaken 
ECM strength and cell-cell junctions within the cell sheets, Kushida’s group found that by using 
temperature variations for cell culture, the same result could be achieved without damage to the 
ECM (Kushida et al. 1999).  
These sheets are then used as a scaffold-like structure and can be seeded with cells for 
three-dimensional tissue engineering purposes, such as creation of blood vessels (L'Heureux et 
al. 2006). L'Heureux’s group was able to create the first implantable and completely biological 
tissue engineered blood vessel by creating cell sheets for a period of 6 weeks by co-culturing 
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fibroblasts and stem cells together, producing ECM sheets. Sheets were then cleaned using the 
temperature variation method and smooth muscle cells were cultured on these sheets over a 
mandrel to maintain a blood vessel shape for a maturation period of 8 weeks. They then lined the 
tissue formation with endothelial cells to form the intima layer of the vascular tissue and found 
three well-defined layers of tissue with a burst pressure strength of about 2000 mmHg. 
Hematology tests and a preliminary in vivo test were preformed that confirmed that the blood 
vessel could be implanted into a living subject (L'Heureux et al. 1998). 
The largest limitation in this technique is the time needed to culture the smooth muscle 
cells (approximately 8 week maturation) (L'Heureux et al. 1998).  Another issue may be with the 
need to use smooth muscle cells from the patient in order to avoid donor-rejection and the time it 
would take to culture the cells (L'Heureux et al. 1998). 
Cell Printing 
Cell printing, also known as Biological Laser Printing or BioLP, is a novel method for 
positioning cells into 3-D constructs (Chen, Barron and Ringeisen 2006). This technology is able 
to process cells into multi-layered culture by using ink-jet printing systems to “print” cells on top 
of each other (Varghese et al. 2005).  In the case of blood vessels specifically, cell printing 
allows very accurate and precise control of tissue size and shape (Zhang et al. 2007). By loading 
cartridges with cells and other biological aids such as growth factors and various other 
biomolecules, this process is able to create a 3-D structure composed of a variety of components 
(Xu et al. 2005, Chen et al. 2006).  Once these multi-layer cultures are formed, they can then be 
placed into a bioreactor for additional culture (Xu et al. 2005). 
Due to the accuracy at which cell printing allows formation of tissue cultures, it has been 
used to create vascular tissue (Cui and Boland 2009). The possible use of this technology could 
be to replace microvascular damage in a patient which would be much more difficult with other 
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tissue engineering methods since there is less accurate control of cell positioning as compared to 
cell printing (Zhang et al. 2007). Cui showed that by printing fibrin fibers for support, 
endothelial cells were cultured into microvascular constructs after 21 days and could ultimately 
become vascular tissue, though smooth muscle cells were not used in the experiment (Cui and 
Boland 2009). 
Cell printing is a robust method to produce a 3-D cell culture, but is yet to be seen as a 
way to create viable tissue due to its inability to produce large massed cell cultures on its own 
and lack of diffusion and transport through large thickness tissue (Varghese et al. 2005).  Though 
cell cultures can be fused together to achieve a desired shape, there is no guarantee that the cells 
will fuse correctly or form enough ECM to hold together. The process is also time consuming 
and costly due to the individual layering of the cells and growth factors, the need to load separate 
cartridges, and the need to program the printer and computer to process and layer the cell culture 
components correctly (Xu et al. 2005, Chen et al. 2006).  
Among all the various methods for blood vessel tissue culture in 3-D, there are still 
several limitations that are not addressed. Though these particular techniques don’t offer a 
complete solution, the ability to use a bioreactor-type device may provide better results and 
address more issues concerning blood vessel 3-D cell culture. 
2.4 Bioreactors for Three-Dimensional Cell Culture 
 
In order to have a better understanding of how to accomplish the objectives of our device, 
we must first look into previous research and designs that have been pursued in the field of 3-D 
bioreactors.  Bioreactors are designed to mimic in vivo conditions while providing adequate 
nutrient diffusion and waste removal.  In order to arrange the cells and support cell growth, 
typically a natural or synthetic scaffold is utilized. There are a number of 3-D scaffold-free 
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bioreactor systems, but methods to control of cell position are limited. Three bioreactor designs 
that are capable of 3-D scaffold-free cell culture include the rotating wall vessel (RWV), dialysis 
tube-roller, and the magnetically stabilized fluidized bed (MSFB). 
Rotating Wall Vessel Bioreactor 
Rotating wall vessel (RWV) bioreactors were initially designed by the National 
Aeronautics and Space Administration (NASA) to protect cell cultures from the extreme forces 
of space shuttle launch and landing.  The cells and media are suspended between two co-rotating 
cylinders, which balance gravitational force with centrifugal force.  This causes the cells to enter 
a constant state of free fall, simulating the effects of microgravity. The RWV bioreactor allows 
the cells to experience minimal shear and contact with the vessel.  Subsequently the bioreactor 
provides high rates of nutrient, waste, and oxygen transport.  The cells aggregate in the center of 
the bioreactor and engage in 3-D cellular interactions, such as extracellular matrix formation and 
signaling (Lappa 2003).  Figure 2.1 is an image of a commercially available RWV bioreactor 
sold by Synthecon Inc. 
 
Figure 2.1: Synthecon rotating bioreactor 
Found at: http://www.bumc.bu.edu/microbiology/files/2009/10/doc2_clip_image002.gif 
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The RWV approach has shown to be promising in the field of tissue engineering and 
long-term organ culture, particularly in the growth of high-density scaffold-free tissues (Ohyabu 
et al. 2006, Sakai et al. 2009, Arrigoni et al. 2008).  One disadvantage of the RWV is that there is 
no way to define and dictate the 3-D shape of the tissue without using a scaffold. Also, the 
effects of microgravity on cell growth are still under investigation (Sytkowski and Davis 2001).      
Dialysis Roller Bioreactor    
A team of researchers from the United Kingdom developed a dialysis tube-roller system, 
shown in Figure 2.2 to culture scaffold-free tendon tissue (de Wreede and Ralphs 2009).  Cell 
pellets and media are added to a dialysis tube, inserted into a media filled centrifuge tube, and 
placed on a roller. The system is allowed to culture for fourteen days.  The researchers were 
successful in producing rod-shaped aggregates with cell orientation similar to that of tendon (de 
Wreede and Ralphs 2009).  Using this method, the cells are undisturbed during media changes 
and experience hemodynamic and physical loads with improved media flow around the 
aggregates (de Wreede and Ralphs 2009).   As with the RWV bioreactor, this system does not 
allow for the manipulation of cell position in order to create a defined shape.  The dialysis tube-
roller system produced a variation of aggregates in each tube including a majority of spherical 
shapes, as opposed to elongated tendon-like fibers (de Wreede and Ralphs 2009). 
 
Figure 2.2: Dialysis tube-roller culture system.  
(de Wreede and Ralphs 2009) 
a. Dialysis tube 
b. Conical tube 
c. Lid 
Cells 
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BioLevitator 
A commercially available bioreactor that has the capability of creating 3-D tissue is the 
BioLevitator®. This device is manufactured by Hamilton Robotics™ and Global Cell 
Solutions™. The BioLevitator® is a bench top culturing device that “aims to streamline the cell 
culture process.” The device uses beads, which are called Global Eukaryotic Microcarriers® 
(GEM). Using the GEM, the device is able to magnetically maneuver the cells into position 
inside a conical tube. These beads have the capability to interact with any type of cell line, which 
allows for greater variety of tissue production (Perea et al. 2006). The device also allows for 
control of temperature and CO2 levels which are vital to cellular growth. It is important to note 
that even though this device has the capabilities to create 3-D tissues, it does have limitations. 
Cells can adhere to the wall of the conical tube which causes cell formations in undesired areas. 
The bioreactor has a static nutrient system which adversely affects diffusion and requires 
frequent media exchange. In addition to these limitations, it has also been shown that the tissue 
thickness is generally not larger than a few millimeters.  
Magnetically Stabilized Fluidized Bed 
Magnetically stabilized fluidized bed reactors allow for continuous fermentation and 
other high-throughput bioprocessing by suspending cells in flow of media with a magnetic field 
(Terranova and Burns 1991).  Cells are bound to magnetic particles and the particles arrange 
themselves along the field lines produced by an electromagnet surrounding the reactor.  Positions 
of the particles can be adjusted by modifying the magnetic field.   
Though magnetically stabilized fluidized bed (MSFB) reactors have not yet been used for 
human cell culture, they may offer a number of advantages in this application.  Having the cells 
attached to these particles would allow them to receive a constant nutrient flow and waste 
removal.  Various bead formations can be formed by altering the magnetic field.  Thus, the 
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MSFB can be used to both culture and orient cells.  MSFB's have been applied to continuous 
yeast fermentation (Ivanova et al. 1996), plant cell culture (Bramble, Graves and Brodelius 
1990), and cell processing (Terranova and Burns 1991).   
One issue which arises with the MSFB is the excessive heat produced by the 
electromagnets, though there has been research on this topic (Terranova and Burns 1991).  
Excessive heating of the bioreactor can cause denaturing of proteins and cell death.  The MSFB 
system allows for some manipulation of cell position, the formation of exact shapes is limited by 
the inability to precisely control the magnetic field geometry.   
Flow-Through Bioreactor 
A team of researchers at Worcester Polytechnic Institute (WPI) led by Christopher 
Lambert, PhD, have developed a ‘flow-through’ bioreactor which incorporates the principles of a 
magnetically stabilized fluidized bed in a simplified form.  A schematic of the design is shown in 
Figure 2.3.  Cells attached to magnetic beads are held in a ring arrangement by a permanent 
magnet and fed by a constant media flow. A schematic of the flow-through bioreactor is shown 
in Figure 2.3.  The device is composed of a glass tube with a neodymium ring magnet positioned 
outside the tube.  The inside of the tube is coated with poly(ethylene glycol) (PEG) to prevent 
cell attachment to the walls.  The magnetic microbeads composed of agarose and iron oxide 
nanoparticles are coated with collagen for cell binding.   Although preliminary results are 
promising, this approach is still in its infancy. The flow-through bioreactor has a number of 
limitations which need to be overcome.  One such limitation is the inability to monitor cell 
growth in a minimally invasive and sterile manner.  Another limitation is that there is no ability 
to monitor bioreactor parameters such as pH, CO2, and temperature to assess bioreactor function 
and media condition. Further, the cells in contact with the glass surface may receive limited 
amounts of nutrients which would be detrimental to tissue formation. 
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Magnetic agarose beads have been used extensively for cell separation (Pope et al. 1994) 
and protein purification (Levisona et al. 1998). The surface of the agarose beads can be 
conjugated with antibodies for specific binding or collagen for non-specific cell binding.  Further 
information on magnetic particles will be provided in the next section.   
 
 
 2.5 Magnetic Cell Positioning 
 
Magnetized cells can be seeded to specific locations using magnetic force which presents 
a number of advantages over other seeding methods for tissue engineering. Two common 
methods of magnetizing cells is by culturing them with magnetic beads or introducing magnetic 
nanoparticles into the cell.  The beads surface can be modified with specific and non-specific 
binding ligands to improve cell adhesion.  DynaBeads®, sold by Invitrogen™, are commonly 
used magnetic beads, but they may be toxic to cells at high concentrations (Tiwari et al. 2003).  
They are composed of superparamagnetic iron oxide particles in a polystyrene shell 
(invitrogen(tm) 2009).  Superparamagnetic particles are magnetized in the presence of a 
magnetic field, but are not magnetic when the field is removed. DynaBeads® have been used to 
Figure 2.3: Flow-through bioreactor. 
Cells on beads 
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seed cells onto a tubular collagen membrane to form a tissue engineered blood vessel (Perea et 
al. 2006).  This technique is also applicable for recreating blood vessel structure by seeding 
multiple cell types in succession (Perea et al. 2006).  This approach was accomplished through 
static culture, not within a bioreactor.          
  Ferrous oxide (Fe3O4) superparamagnetic nanoparticles have been delivered to cells and 
used to make tubular cell constructs (Ito et al. 2004).   The nanoparticles were encapsulated in 
cationic liposomes in order to facilitate the nanoparticle delivery.  The positively charged 
liposomes are attracted to the negatively charged cell membrane, enter the cell and release the 
nanoparticles (Ito et al. 2005).  The magnetite-loaded cells were cultured into sheets and then 
rolled onto a magnetic rod to form tubes (Ito et al. 2005).  This method is called Mag-TE by the 
authors and is described as an efficient approach to form high-density 3-D tissue constructs.  
Directly loading magnetic particles into the cell could affect cellular function.  Iron oxide 
nanoparticles have been shown to decrease smooth muscle cell viability (Zhang et al. 2009), this 
may be related to the poor mechanical properties of the cultured tissue (Ito et al. 2005).  Another 
disadvantage of this method is that tube formation required multiple tissue culture steps.  First 
the cell sheet needed to form, then the magnetic rod rolled over the sheet and finally the 
construct was placed in a bioreactor to complete culture. However, this technique demonstrates 
the promise of magnetically charged cells in tissue engineering. 
2.6 Patent Search 
Patent # US 4,833,083  
A 1989 patent describes a bioprocessing reactor consisting of cells or enzymes bound to 
microcarriers in a packed bed.  A radial flow of media allows for continuous perfusion of the 
microbead bed.  The high surface area of media flow and cell binding surface area allows for 
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high density culture.  This bioreactor, shown in Figure 2.4, is designed for the high throughput 
production of proteins or other cell culture derived molecules (Saxena 1989). 
 
Figure 2.4: Packed bed bioreactor.  
(Saxena 1989) 
 
Patent # US 4,988,623 
Rotating Wall Vessel bioreactor technology has been marketed by Synthecon 
Incorporated™ and is available in both disposable and autoclavable designs. This technology is 
based on patent number 4,988,623 for a “Rotating bio-reactor cell culture apparatus” (Schwarz 
and Wolf 1991). This patent was also expanded into a patent for a “Three-dimensional cell to 
tissue assembly process” using the same rotating bioreactor while adding microcarrier beads to 
increase cell attachment surface area (Wolf et al. 1992).  
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Patent # US 5,605,835 
R.A. Shatford et al of the University of Minnesota designed a bioreactor with cells with a 
culture chamber separated from a ‘waste chamber’ by a selectively permeable membrane.  A 
schematic of the design is shown in Figure 2.5.  The cells are seeding into a fibrous gel which 
allows for the diffusion of the waste through the membrane and into the surrounding media 
stream (Hu et al. 1997).  This bioreactor was designed to function as an extracorporeal liver 
assist device, with hepatoctyes seeded in the gel matrix.   
 
Figure 2.5: Bioartifical liver bioreactor.  
(Hu et al. 1997) 
  
Patent # US 5,827,729 
 Advanced Tissue Sciences holds a patent for a bioreactor which provides cells seeded 
onto a mesh with two separate media flows.  The reactor could also potentially function as an 
extracorporeal liver assist device if used with liver tissue.  Nutrients can be delivered to the cells 
by a concentration gradient between the two media flows (Naughton, Halberstadt and Sibanda 
1998).  The bioreactor can be seeded with cells which produce a desired protein, such as 
albumin, and the product harvested from either the media flows (Naughton et al. 1998).  The 
30 
 
device, shown in Figure 2.6, can be used for co-culture of cells such as hepatic stormal and 
acidophilic cells (Naughton et al. 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Diffusion gradient bioreactor. 
(Naughton et al. 1998) 
 
Patent # US 6,632,658 B1 
Levitronix LLC patented a bioreactor which suspends tissue in fluid flow (Schoeb 2003).  
The device uses a cone to maintain a fluid flow gradient opposing gravity with the tissue in 
equilibrium.  The device can either suspend a tissue mass (with a scaffold) or cell pellets.  
Though this bioreactor cannot control cell position, it does provide an example of the application 
of fluid flow to control bulk position and cell suspension.   A schematic of this bioreactor design 
is shown in Figure 2.7. 
Media flow 
Cells on 
mesh 
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Figure 2.7: Flow suspension bioreactor.  
(Schoeb 2003) 
  
Cell pellets 
Fluid flow 
Reservoir 
Pump 
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Chapter 3  Project Strategy 
 
Following the prescriptive design process (Dym and Little 2004), the team initially 
clarified the client statement and design objectives.  The client gave the design team a project 
outline, a timeline on expected deliverables, as well as a general client statement.  A Gantt chart 
was created to plan the project timing (Appendix A).  The initial client statement was, “Generate 
a ring of tissue in a flow through bioreactor that includes some engineering refinements that 
allowed for non invasive monitoring of the system”.  The team set out to clarify this general 
statement through a series of client meetings and brain storming sessions. A detailed client 
statement was constructed and several design tools were used to aid in developing a preliminary 
design.  Key components of the preliminary design were validated to fulfill client’s objectives 
and a final design was constructed.   
3.1 Objectives 
 
 To conceptualize the design and focus the design space, a list of general objectives and 
constraints were determined through discussion with the client. The objectives and constraints 
were developed with a combination of background research, interviews, and team meetings.  The 
design team narrowed the objectives into five topics that the client conveyed were vital.   
The device should ultimately culture a 3D tissue construct and provide adequete nutrient 
diffusion to sustain the tissue growth.  The bioreactors flow system should support a tissue of 1 
mm thickness without necrosis in the center.  A tubular tissue shape composed of smooth muscle 
cells was specified as the 3D cell culture model due to its applicability to blood vessel tissue 
engineering.  At minimum the bioreactor should form a ring of tissue with a diameter of 5 mm.  
The device should have the capabality of seeding multiple cells types and efficiently position the 
seeded cells.  This objective is applicable to recreate the layers of a blood vessel or form other 3-
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D co-cultures, thus it was specified that the bioreactor should have the capability to seed three 
subsequent layers of cells.  It was also specificed that the bioreactor be capabable of seeding a 
miniumum of 2 x 106 cells.  The clients also expressed the importance of the ability to sample 
and asses bioreactor paramters and tissue growth.  Ease of sampling was an objective the client 
deemed vital in order to allow understanding of the development of the tissue, as well as possible 
extraction of cells while still keeping the bioreactor running and sterile.  The design should be 
easily reproducable and require minimal machining.  Ideally multiple bioreactors can be easily 
manufactured and tested simultaneously.   
A pair-wise comparison chart, shown in Appendix B, was completed in order to rank top-
level objectives.  The main purpose of the pair-wise comparison chart is to narrow down the 
components of the design that are vital to the client, as well as to allow the design team to focus 
on the most important objectives (Dym and Little 2004).  The pair-wise comparison chart given 
to the clients and rankings were given on a 0 or 1 scale on which objective was more important 
than its comparison, 1 meaning that the objective on the left was more important and 0 meaning 
the top objective was more important. The design team also ranked the objectives as shown in 
the grey boxes.  The pair-wise comparison chart yielded a 3-D  tissue was the most important 
objective (4 points) followed by efficiency in cell positioning (2 points), ease of sampling (2 
points), seeding of multiple cell types (1 point), and ease of manufacturing (0 points). 
The rankings from the pair-wise comparison chart were used to create a weighted 
objectives tree shown in Figure 3.1. The purpose of the weighted objectives tree is to consider 
the objectives as taken from the pair-wise comparison chart and separate them into quantitative 
considerations for planning the design (Dym and Little 2004).  The chart shows that the client 
deemed a three-dimentional tissue as the most important objective with multiple cell types and 
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ease of sampling tied for second. Efficiency in cell positioning and ease of manufacturing were 
deemed objectives of lesser importance. These ratings allowed for a more focused attention on 
the most important objectives and meeting what was vital to the project while also listing other 
possible considerations for the device design. 
 
Figure 3.1: Weighted objectives tree. 
 
The team created a list of possible constraints that needed to be considered during the 
brainstorming phase of the design process (Dym and Little 2004). The project had a budget of 
$468 and a deadline of April 22, 2010.  It was critical that the device fit on an incubator shelf, 
thus size was a significant constraint.  It was also necessary that the materials chosen to build the 
device were capable of being sterilized and biocompatible with the cells used.   
3.2 Revised Client Statement 
 
Based on the initial client statement, several meetings with the client, and clarification of 
design objectives, the design team was able to refine the client statement further.   
 
The goal of this project is to create a magnetic bioreactor for three-dimensional 
cell culture and produce tubular tissue construct which can be used for blood 
vessel tissue engineering. The bioreactor will allow for manipulation of cell 
position into the three-dimensional shape without the use of a scaffold and 
provide continuous nutrient support to the tissue.  The bioreactor should allow for 
sterile sampling of the tissue growth and produce an easily removable, three-
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dimensional tissue construct.  The design should be easy to replicate and require 
minimal machining.  The project should be completed within the $468 budget and 
by the April 22nd, 2010 deadline 
3.3 Bioreactor Functions 
 
 The design team determined four basic functions required to fulfill the client’s objectives, 
summarized in Figure 3.2.  The bioreactor should be able to seed a high density of cells 
uniformly over the specified area and prevent exogenous tissue growth in other areas of the 
reactor.  This is necessary to accomplish the efficiency in cell positioning objective.  The 
bioreactor should position the cells into a tubular shape or tissue ring for blood vessel tissue 
engineering.  The tissue needs to receive sufficient nutrient support throughout the thickness of 
the culture, preventing cell death in the center and aiding in the recreation of in vivo morphology.  
Finally, the bioreactor design should incorporate the easy removal of the cultured tissue and 
sterile sampling ports to assess bioreactor performance. 
 
Figure 3.2: Bioreactor functions. 
•Seed high density of cells
•Seed and position multiple cell types
•Limit exogenous tissue growth
Uniform cell seeding
•Formation of tissue ring 
•Blood vessel
Tubular tissue construct
•Prevent necrosis of three dimensional tissue
•Provide nutrient diffusion to entirity of tissue
•Continous nutrient flow
Optimal support of cell growth
•Removing tissue intact
•Sampling biological product
Removable product
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Chapter 4 Alternative Designs 
 
 
Through brainstorming with the assistance of the design tools described in Chapter 3, the 
design team decided upon four alternative designs for the bioreactor.   The designs are based on 
fulfilling the top-level objectives.  Specifically, conceptual designs were developed that had the 
capability to control cell position and provide appropriate conditions for the formation of a 3-D 
tissue. The key features of each design were divided into three components; the type of magnetic 
array, cell seeding method, and flow system. Decision matrices (Appendix D) were used to 
determine optimal features of each design and a preliminary design was developed based on 
these results.  Computer-aided design software, SolidWorks 2009, was used to construct 3-D 
models of the alternative designs.  
4.1 Functions-Means Tree 
 
The design team created the functions-means tree shown in Figure 4.1; which was used to 
assist in brainstorming conceptual designs. The tree is meant to be present solutions to the 
necessary functions of the design described in Chapter 3. The function-means tree shows several 
means, shown in the rounded bubbles, to accomplish each function, denoted in the square boxes 
at the top of each column. This would ultimately aid in developing possible design alternatives to 
meet the primary objectives set by the client.  
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Figure 4.1: Functions-means tree. 
 
In order to achieve uniform cell seeding, possible solutions may be syringe injection of 
cells to allow direct and controlled placement. Another solution may be rotating the bioreactor to 
allow for even coating and formation of a cylindrical shape. The bioreactor could also be rolled 
and the cells would attach to it, or a Halbach array could be used to control where cells attached. 
A Halbach array creates a homogenous magnetic field by positioning permanent magnets in 
specific locations and orientations around a ring (Raich and Blümler 2004).  The magnetic field 
flux can be inside or outside the ring depending on the magnet arrangement (Raich and Blümler 
2004).  This field can be used to position the beads into a ring or potentially tube shape. 
Optimal support for growth could be met by suspending the cells in media, using a semi-
permeable membrane to allow increased diffusion of nutrients into the cell culture. Controlled 
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media flow could be used to allow for better nutrient support. Alternative means would be to 
suspend cell pellets or cells attached to beads in a flow of media. 
A removable product could be achieved in several ways, through the use of a non-
adhesive surface, a floating bioreactor so that the device itself could be removed from the tissue, 
or creating a removable device piece or membrane so that the tissue would not be compromised.  
Monitoring certain aspects of the bioreactor would also be important to consider, 
including pH, CO2 levels and temperature. The bioreactor could include means to monitor these 
parameters in a minimally invasive manner.  Cell growth could also be monitored by allowing 
tissue samples to be removed while maintaining culture sterility. 
4.2 Design Approaches 
Magnetic Rod Bioreactor 
The bioreactor design in Figure 4.2 consists of a polymer coated magnetic rod within a 
media filled chamber.  Magnetic particles seeded with cells are loaded into the device and are 
attracted to the magnet.  The magnetic rod is coated with polymer so that the cells are not in 
contact with metal and do not adhere to the surface.  The cells are fed with continuously flowing 
media.  The bioreactor can also be rotated for improved cell seeding, nutrient transport, and 
mechanical conditioning.  Additional layers of different cell types could be added to the device, 
allowing for the recreation of a blood vessel or other composite tissue.  The magnetic rod array 
would be simple and inexpensive to fabricate.  This design succeeds in positioning cells, 
supporting multiple cell types and forming a 3-D construct. However, there may be reduced 
nutrient transport to the cells in contact with the magnetic surface. Another limitation is that it 
may be difficult to remove the final tissue from the device, especially taking into account the 
attractive forces exerted by the magnets. 
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Figure 4.2: Magnetic rod bioreactor. 
 
External Magnet Array Bioreactor 
The design alternative shown in      Figure 4.3 suspends cells (on magnetic carriers) 
within semi-permeable dialysis tubing and attracts them to the surface of the tubing by magnetic 
force.  This design allows for nutrient transport and waste removal to occur both within the 
center and outside of the dialysis tube.  The dialysis tube or the whole bioreactor could be rotated 
for improved cell seeding.  The strength of the magnets used could be a limiting factor in this 
design due to the increased distance between the magnets and magnetic beads.  Also, increased 
difficulty could arise when removing the cultured tissue due to the possibility of the dialysis tube 
collapsing upon itself.  However, it may be easier to remove the tissue from this design than the 
magnetic rod design because the beads would not be directly contacting the magnet. 
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Internal Magnet Dialysis Bioreactor 
The third conceptual design (Figure 4.4) is a combination of the magnetic rod and 
external magnet arrays. The magnets are placed in a staggered arrangement within a semi-
permeable membrane. They are positioned using a machined plastic cylinder with grooves for 
the magnets and holes for media flow. Cells seeded on magnetic beads would be attracted to the 
tube and held in place by the magnetic field. Combining this arrangement with media flow would 
allow nutrients to diffuse outward, through the membrane, and feed cells in contact with it. There 
would also be a flow of media outside the membrane, allowing cells to be fed from both sides. 
This approach could be accomplished with permanent magnets, reducing cost and negating the 
heat issues associated with electromagnets. This bioreactor also allows for enhanced nutrient 
transport and waste removal, due to the two flow paths, while the media within the bioreactor 
and dialysis tube could be sampled to assess bioreactor function. The tissue could be easily 
removed and analyzed by removing the dialysis membrane from the central tube. 
     Figure 4.3: External magnet dialysis bioreactor 
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Figure 4.4: Internal magnet dialysis bioreactor. 
 
Halbach Array Bioreactor 
The design in Figure 4.5 is based on the principle of magnetic fields and repulsing forces.  
The device will have a total of twelve magnets, arranged in a Halbach cylinder.  This specialized 
magnetic arrangement can produce a uniform magnetic field in the center of the cylinder. 
Magnetic beads would levitate in the device, supported by the uniform field of the Halbach 
array.  Such a design would allow the beads to be suspended with maximal nutrient transport to 
the cells and simplified tissue removal.  This design could be hampered by the inability to 
accurately position the beads onto a surface, making it difficult to create a tubular construct.   
Magnet Media 
ports 
Magnet 
fixation 
Holes for 
media flow 
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Figure 4.5: Halbach array bioreactor. 
4.3 Design Selection 
 
A decision matrix is an engineering design tool used to make design decisions.  Each 
design alternative is given a rank from 0 to 2 based on its adherence to given objectives, 
functions, and constraints.  The design alternative with the highest total score is considered 
suitable for further development.  Decision matrices were created for the bioreactor’s magnet 
array, cell seeding method, and flow system (Appendix D).  The values were tabulated for these 
aspects of each conceptual design and the highest ranked approaches were incorporated into the 
preliminary design.   
Magnet Array 
The magnetic array decision matrix yielded the dialysis tube with internal magnets as the 
optimal method to position the magnetic beads (Appendix D).  This method allows for the 
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accurate positioning of cells within the device, high levels of nutrient transport on both sides of 
the tissue, and the possibility of incorporating sterile sampling functionality.  
Seeding Method 
After the magnet array was specified, it was important to determine optimal technique to 
introduce beads into the bioreactor with an even distribution throughout the central tube. This is 
important to prevent cell accumulation in one particular area leading to uneven tissue growth.  
The team determined syringe injection, manual rolling, automated rolling, and pouring as 
possible methods to seed the agarose microbeads into the bioreactor. Syringe injection would 
involve either ports for a needle or luer-lock connections on the device.  Beads could be injected 
from multiple locations on the bioreactor thus aiding in even bead distribution.  It would be 
necessary to determine the optimal needle gauge and flow-rate to prevent cell detachment from 
the beads.  A schematic of this method is shown in Figure 4.6. 
 
Figure 4.6: Syringe bead seeding method. 
 
Alternatively, the magnetic tube could be manually rolled in a microbead solution.  This 
would guarantee and even distribution of particles on the tube’s surface. Though multiple cell 
types could be seeded initially, it would be difficult to seed additional cells during culture, 
because the bioreactor would need to be disassembled to remove the magnetic tube and roll it in 
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another bead solution. There would also be complications in maintaining sterility, because the 
cells are seeded externally and then introduced to the bioreactor.  A schematic of this method is 
shown in Figure 4.7. 
 
Figure 4.7: Manual rolling bead seeding method. 
 
 An automated roller system could be used to seed the beads and cells onto the magnetic 
rod.  Media containing cells attached to magnetic beads could be pipetted directly into the 
bioreactor.  The device can then be placed on a laboratory conical tube roller for a designated 
period of time.  The purpose of the rotation is to aid in even seeding of the beads on the magnetic 
tube.  This method is dependent on the rate of bead attachment to the magnets.  If the beads 
attach almost instantaneously, there would be an insufficient amount of time to disperse the 
beads using the roller method.  There could also be contamination issues involved with pipetting 
media into the device.  A schematic of the automated roller method is shown in Figure 4.8. 
 
Figure 4.8: Automated roller bead seeding. 
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The final proposed method is to add the magnetic beads (with cells attached) directly into 
the media reservoir.  A peristaltic pump would be used to transfer the beads into the bioreactor 
and disperse them along the magnetic tube.  The rate of bead seeding and distribution could be 
controlled through the flow rate of the pump.  A higher flow rate would result in a more rapid 
introduction of beads into the bioreactor. A greater spread of beads over the rod could be 
achieved with this method, while increasing risks of cell detachment from the beads.  Bead 
distribution could not be controlled to a great degree of accuracy but this method would maintain 
sterility of the device, because no external pouring or rod removal is necessary.   
 Syringe injection yielded the highest point total in the bead seeding decision matrix 
(Appendix C). This approach allows for accurate and controlled bead positioning while 
maintaining a sterile bioreactor environment.  Luer-lock connections were chosen to provide a 
secure and standardized syringe port.  These connections can be positioned in optimal locations 
on the bioreactor housing for uniform bead seeding. It is also necessary to specify loading rate 
and syringe size, parameters determined through flow calculations and experimentation.  
Flow System 
The flow system was an important design parameter which needed to be determined.  The 
most basic setup would involve a single media reservoir which would supply both fluid flows in 
the bioreactor.  This would be inexpensive to manufacture and would require only one pump.  A 
disadvantage of this setup is that detached cells would enter the shared media reservoir and 
would be transferred into the magnetic tube.  Thus the media would need to be replaced more 
frequently and there could be cellular growth inside the magnetic tube causing decreased nutrient 
transfer across the dialysis membrane.  Also, there would be limited control of the flow rate in 
the magnet tube and bioreactor housing. 
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The second approach involves using two media reservoirs and two pumps.  One reservoir 
would provide clean media to the magnetic tube and the second reservoir would circulate ‘dirty’ 
media in the bioreactor housing.  The advantage of using two pumps is that the flow rate in the 
magnetic tube and housing can be controlled individually and an optimal flow rate determined.  
The optimal flow rate would provide the highest levels of nutrient and gas transport through the 
dialysis tube and minimal levels of shear on the external cell layer.  Dialysis tube function could 
be quantified by comparing the composition of media in the reservoir supplying the dialysis tube 
to the bioreactor housing reservoir.  This approach would be more expensive due to the two 
pumps and require larger amounts of media to operate.  A multi-channel pump would also satisfy 
this design, however flow rate could not be controlled as easily as a two pump system.  A 
schematic of the dual reservoir system is shown in Figure 4.9. 
 
Figure 4.9: Dual reservoir flow system. 
 
Another flow system was proposed which incorporates a semi-permeable membrane to 
separate cell-free media and media with cells.  This system could provide clean media to both the 
magnetic tube and bioreactor housing, limiting extraneous cell growth in the device. Media 
exiting the bioreactor would pass into the first section and be filtered through the dialysis 
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membrane to be pumped back into the device.  This design could incorporate either a single 
pump or two pumps for improved flow control.  A schematic of the semi-permeable membrane 
flow system is shown in Figure 4.10. The flow system decision matrix yielded the dual reservoir 
approach as the optimal flow system for the bioreactor.   
 
Figure 4.10: Semi-permeable membrane flow system. 
 
4.4 Preliminary Design 
The results of the decision matrices were used to develop a preliminary design.  This 
design incorporates the internal magnet dialysis tube, syringe injection bead seeding and a dual 
reservoir flow system.  SolidWorks 2009 was used to build a 3-D model of the preliminary 
design, determine appropriate dimensions and guide fabrication of the device.  A model of the 
preliminary design is shown in Figure 4.11. All dimensions listed are in millimeters. 
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Figure 4.11: CAD drawing of preliminary design. 
 
 The preliminary design is composed of a dialysis tube and housing with independent 
media flow systems.  In the center of the dialysis tube is an array of two magnets, secured on a 
threaded rod with hex nuts.  The dialysis tube runs over the magnets and is secured by zip-ties to 
two graduated pipette end pieces.  The pipette ends are inserted into rubbers stoppers with holes 
for media flow.  A model of the magnetic tube is shown in Figure 4.12. All dimensions listed are 
in millimeters. 
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Figure 4.12: Magnetic rod assembly. 
 
 The bioreactor housing is a tube which is sealed by the rubber stoppers.  This could be 
fabricated by cutting the end off a conical tube, thus expensive machining is not required.  Luer-
lock connections could be attached on the surface of the tube, enabling the injection of media or 
magnetic bead solution.   
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Chapter 5 Design Validation 
 The central aspects of the bioreactor design included the ability to attach cells to 
magnetic beads, attract the beads to a magnet, and provide nutritional support to the culture with 
a dual-flow dialysis tube system.  These principles behind the design were validated prior to 
testing the final design of the bioreactor.   
5.1 Homogeneous Magnetic Field 
 Due to the incorporation of magnetized beads for cell positioning within the bioreactor, a 
homogeneous magnetic field was of significant importance. The need for such a field was to 
assure that the beads would spread evenly around the bioreactor. This would allow for a more 
confluent cell growth around the inner tube of the bioreactor.  
In order to determine if the device had a homogeneous magnetic field to which the beads 
and cells could attach to, a particular magnetic paper was used that was designed to allow a 
visual demonstration of where the magnetic fields lines were located, when placed over an 
object. This paper, sold through Millipore, contained a slurry of ferromagnetic nickel particles.  
With an absence of a magnetic field the paper appeared green, but when a magnetic object is 
placed under the paper, the magnetic slurry is displaced which changes the papers color from 
green to black. Below is an image of the magnetic paper without any object or magnetic field 
underneath it. 
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Figure 5.1: Blank magnetic paper.  
 
In order to test whether the orientation of magnets would produce a homogenous 
magnetic field, this magnetic paper was used to give a visual representation. Using the rare earth 
magnets purchased for our design, they were assembled in various orientations on the nylon rod 
in order to determine which set up would produce the most homogenous magnetic field and thus 
allow for a more even distribution of magnetic beads on our magnets. The magnets, purchased 
through KJ Magnets, were N52 neodymium rare earth magnets, which denote the type of 
material used (N for neodymium) and the strength of each magnet on a scale of 42-52, in which 
52 is the highest strength magnet. These magnets were polarized from horizontally, meaning that 
the top half of the magnet was polarized north while the other was polarized south. The image 
below shows one magnet with the north and south ends labeled for a clearer understanding of 
how the magnets are polarized.  
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Figure 5.2: Magnetic array with magnet polarization labeled. 
 
The magnets needed to be separated so that the field is homogenous across the length of 
the rod. Previous research with homogenous magnetic field testing was referenced in order to 
make a homogenous magnetic field (Okuda 1995, Okuno 1997). The exact distance of separation 
depended on several variables including type of magnets used and strength of the magnets. Since 
no literature could be found referencing N52 magnets, the team decided to try variable distances 
and use the magnetic paper to visually check how homogenous the magnetic field was. The 
magnetic field was tested with a nylon hex nut (6.35 mm), nylon washer (3.17 mm) and no 
spacer between the magnets to see which produced the most homogenous field. The ideal 
outcome of the test would be to see the magnetic paper turn black evenly along the entire length 
of the rod. This would show that there was a completely homogenous field around the magnets 
and rod and that no spaces existed where there was no magnetic field.  
The first test was conducted testing the magnetic field with a nylon hex nut between the 
two magnets.  Figure 5.3 shows the magnetic rod (left) and field on magnetic paper (right).  
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Figure 5.3: Visualization of magnetic field from 6.35mm magnet spacing. 
 
From the image on the magnetic paper, it was determined that the magnetic field did not 
look uniform around the inner rod. There were clear holes of green were the field was not 
effective, specifically around the inner hex nut as well as directly in half of each magnet. The 
holes in the middle of the magnet were determined to be due to the polarization of the magnet 
(each magnet was magnetized North and South in half from left to right as shown in Figure 5.2). 
The next test that was conducted was to see if no hex nut would produce a more homogenous 
magnetic field since the use of the hex nut caused a void in middle of the rod.  The results are 
shown in Figure 5.4. 
 
Figure 5.4: Visualization of magnetic field with no magnet spacing.  
 
The results of the test showed that this setup generated a less homogenous field, creating 
a large void in the middle of the rod and two homogenous fields on the end. This would result in 
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large clumping when beads were introduced and would not produce an even distribution of cells 
along the entire length of the bioreactor. It was speculated that these results were produced due 
to the polarization of the magnets. The magnets produced a strong attractive field where they 
would touch, but produced a large resistive field half way between them since the magnets are 
polarized north and south on the left and right sides, as seen in the picture. This polarization 
causes the fields to cancel each other in that area, producing no magnetic field and thus a less 
homogenous image. The last test that was conducted was to place a thin nylon washer between 
the magnets instead of the nylon hex nut. It was thought that this might allow for a more 
homogenous magnetic field than the nylon hex nut because the magnets would be slightly closer 
together, but not close enough to where a large void would be generated in the center of the rod. 
The field resulting from the 3.17 mm magnet spacing is shown in Figure 5.5. 
 
Figure 5.5: Visualization of magnetic field 3.17 mm magnet spacing. 
 
This set up produced a much smaller gap between magnets, but there was still a small 
area where the field was not homogenous located in the middle of the magnets on the nylon rod. 
Though the result did not show a completely homogenous magnetic field, the voids in the field 
were due to the magnets themselves and seen in both the test with no spacer and with the nylon 
hex nut. What the nylon washer did show was a stronger and more uniform magnetic field in the 
center of the rod.  
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Taking into consideration the results of all three tests, it was determined that using the 
washer between the magnets produced the most homogenous magnetic field out of the three 
methods tested. Though using different magnets may help in making the magnetic field more 
uniform such as the use of concentrically polarized magnets (polarized north and south from the 
inside to the out respectively) due to lack of availability and time constraints, this was not 
possible for the purposed project.  
5.2 Agarose Magnetic Beads 
 Collagen-coated agarose beads were fabricated based on a protocol developed by Dr. 
Christopher Lambert’s lab at WPI.  The beads were prepared through an emulsion of a melted 
3% agarose/iron oxide nanoparticle solution in soybean oil.  Bead formation was confirmed with 
light microscopy as shown in Figure 5.6. Carboxyl groups were activated on the beads, enabling 
the binding of collagen onto the surface of the beads by the formation of amide bonds.  The 
beads were sterilized with 70% ethanol prior to activation and coated with sterile Bovine Type 1 
collagen (Advanced BioMatrix).  While agarose typically does not support cell adhesion, cells 
can bind to the collagen coating with integrins on the cell surface (Humphries 2000).   
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Figure 5.6: Magnetic beads, 100X magnification. 
 
Bead Fabrication 
It was necessary for the iron oxide particles to be of nanoscale for them to fit within the 
agarose beads and exhibit superparamagnetic properties (Tong and Sun 2001).  The size of iron 
oxide particles was validated with oil-immersion light microscopy.  Precise measurements of the 
particles could not be obtained with the microscope available but the size scale was determined.    
The iron oxide particles were produced in the form of a ‘magnetic fluid’ or iron oxide particles in 
a dodecanoic (lauric) acid solution.  The lauric acid was necessary to prevent particle 
agglomeration, maintaining the nanoscale particle size (Tong and Sun 2001).  The magnetic fluid 
was prepared by dissolving Iron (II) chloride tetrahydrate (Alfa Aesar) and Iron (III) chloride 
hexahydrate (Alfa Aesar) in a lauric acid (Alfa Aesar) solution and precipitating out iron oxide 
with ammonia.   
100 μm 
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A schematic of the bead fabrication process is shown in.  The magnetic fluid was diluted 
by a factor of 2 with distilled water and brought to a pH of 7.0 with ammonia.  The pH 7 
magnetic fluid was combined with melted 3% SeaKem LE agarose (Lonza) in distilled water.  
This solution was maintained at 90 °C in a water bath (for agarose to remain as a liquid) and 
added to soybean oil (Spectrum) with Polysorbate 80 (JT Baker) drop-wise using a 3mL syringe 
and 18G needle, under stirring conditions (630 rpm) in the 90 °C water bath.  The water phase 
(containing agarose and iron oxide) is insoluble in the soybean oil and forms droplets.  The iron 
oxide is hydrophilic and remains within the agarose solution rather than dispersing in the oil.  
Polysorbate 80 was added to the soybean oil to act as surfactant, stabilizing the agarose droplets 
in the oil.  After stirring for 10 minutes, the emulsion was cooled to around 10 °C to gel the 
agarose droplets and form the beads.  The emulsion was stirred for another 20 minutes while 
maintaining the temperature at 10 °C.  The resulting agarose beads were rinsed with acetone to 
remove any soybean oil, then rinsed with distilled water and passed through a 100 μm cell sieve 
(BD Biosciences).     
 
Figure 5.7: Bead fabrication schematic. 
 
Agarose with 
iron oxide Magnetic 
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Activation and Collagen Coating 
Carboxyl groups were coupled to the surface of the beads in order to facilitate collagen 
attachment.  ‘Inactivated’ carboxyl groups on the beads cannot react to form amide bonds 
without high temperatures or the presence on an initiator.  Activation was accomplished by 
soaking the beads in a solution of .02M N-Hydroxysuccinimide (NHS) and .1M 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC).  The EDC is a carbodiimide which loosely binds to 
the carboxyl groups on the agarose.  The NHS displaces the EDC, forming a more stable 
structure.   NHS coupled to the carboxyl groups allows for the formation of amide bonds in the 
presence of an amine (such as L-lysine on collagen).  The beads were placed on a shaker at low 
speed and allowed to soak in the EDC/NHS solution for 20 minutes.  They were then rinsed with 
distilled water and coated with collagen in a 9.6pH buffer solution.  The beads were stored in 
distilled water until they were ready to use.   
Aniline blue was used to verify the presence of collagen on the beads surface (Figure 
5.8).  Bead which were active but uncoated were stained with the aniline blue as a control 
(Figure 5.9).  Beads were visible with blue traces attached however a majority of beads did not 
appear to stain positive.   
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Figure 5.8. Collagen-coated beads stained with aniline blue, 100X magnification 
 
Figure 5.9: Uncoated beads stained with aniline blue, 100X magnification 
100μm 
100 μm 
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Commercially Available Beads 
Agarose magnetic beads were purchased from BioScience Bead Division of CSS Inc.  The 
beads were 75-150 μm in size and carboxymethyl groups were conjugated to the surface. The 
same bead activation and collagen coating protocols as the manufactured beads were repeated for 
the commercially available beads.  The collagen-coated beads were stained with aniline blue and 
compared to uncoated stained beads as shown in Figure 5.10 and Figure 5.11 respectively. 
 
Figure 5.10: Uncoated stained BioScience beads, 100X magnification 
100 μm 
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Figure 5.11: Collagen-coated stained BioScience beads, 100X magnification 
 
5.3 Cell-Bead Attachment 
Rat aortic smooth muscle cells (RASMCs) were chosen as the cell type based on 
availability and budget constraints.   It was necessary to validate the principle that cells can be 
attached to collagen-coated beads and to estimate the numbers of cells attached per bead.  A 
number of methods were tested and the optimal seeding method was determined. Prior to cell 
attachment, the beads were centrifuged and the distilled water was removed.  They were rinsed 
three times with PBS, centrifuging and removing supernatant between each rinse.  A final rinse 
with cell culture media was performed and supernatant was removed. Protocols for bead 
fabrication and cell attachment are described in Appendix E.  
100 μm 
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Static Seeding: 
The simplest method of attaching the beads to cells was evaluated.  Approximately 
50,000 collagen-coated agarose beads were added to a 1.5ml Eppendorf tube with 2 x 106 cells in 
1ml of media.  The Eppendorf tube was placed in an incubator (37 °C, 5% CO2) and 20µl 
samples were taken at 30 minute intervals.  The samples were placed on a glass slide and 
observed with an inverted microscope as shown in Figure 5.12.  After two hours, cells attached 
to some of the beads, however a number of beads had no visible cells attached.  Thus alternative 
methods of cell-bead attachment were pursued.   
 
Figure 5.12: Static cell-bead seeding, 100X magnification.  
Hanging Drop: 
 The hanging drop technique utilizes gravity to enhance cell bead interactions and 
seeding.  A cell/bead solution in media is dropped onto the cover of a tissue culture plate and 
inverted over a plate filled with media.  The cells and beads settle to the bottom of the droplet, 
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increasing the probability that cell binding will occur.  The media within the dish prevents the 
droplets from drying.  An illustration of this technique is shown in Figure 5.13. 
 
 
 
 
 
 
 
 
 
 
 
 
A concentration of 2 x 106 cells in 1ml of media were added to an Eppendorf tube 
containing approximately 50,000 beads.  20 μl droplets were formed on the tissue culture plate 
cover using a micropipette.  The cover was inverted and placed over a tissue culture dish filled 
with media.  The hanging drop system was allowed to culture for 30 minutes.  The cover was 
removed from the dish and placed on an inverted microscope for observation.  As shown in 
Figure 5.14, a high concentration of cells was visible around the beads with a significant amount 
of cell attachment.  However, the feasibility of this technique is limited by the small volume of 
the droplets making it difficult to seed a significant quantity of beads with cells. 
Cell + bead solution 
Culture plate cover 
Culture plate cover 
Media 
Invert 
Droplet close-up 
Bead 
Cell 
Cover 
Figure 5.13: Hanging drop method. 
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Figure 5.14: Cell-bead attachment with hanging drop technique, 200X magnification. 
 
Dynamic Seeding: 
In order to improve the binding efficiency of the cells in a sufficient volume, the solution 
of beads and cells in media was placed on a rotator and incubated for 2 hours.   The solution was 
rotated at low speed, based on the DynaBeads® ClinExVivo cell isolation protocol by Invitrogen 
(Dynal 2007).  After incubation, 50 μl of the media was placed on a microscope slide and imaged 
with a phase contrast microscope.  The number of cells per bead was counted in 7 fields of view 
at 100X magnification.  The cells appear bright due to the difference in light diffraction from the 
cell compared to direct light entering the objective.  A total of 63 cells were counted on 19 beads 
or an average of 3.3 ± .49 cells/bead.  The cell count had a standard deviation of 2.16 cells.  One 
field of view at 100X magnification is shown in Figure 5.15; white arrows denote smooth muscle 
cells attached to beads. A field of view at 200X magnification is shown in    Figure 5.16. 
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Figure 5.15: RASMC attached to collagen-coated beads, 100X magnification. 
 
   
   Figure 5.16:  RASMC attachment to collagen-coated beads, 200X magnification. 
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5.4 Bead Mobility Validation 
 The maximum distance to attraction of the beads by a magnet was assessed.  The purpose 
of this test was to determine the susceptibility of the beads to the magnetic field and the 
feasibility of positioning the beads with a magnet.  The test would also aid in determining 
dimensions for the design where all seeded beads can attach to the magnet.  A tissue culture dish 
was marked at .5 cm increments along the diameter.  A magnet was placed at one end of the dish 
and 50 μl of bead suspension was ejected at .5 cm intervals toward the magnet.  The test was 
performed with 5 mm outer diameter X 3.1 mm inner diameter X 5 mm long and 12.7 mm outer 
diameter X 6.35 mm inner diameter X 12.7 mm long cylinder magnets.  The magnets were 
wrapped in Teflon tape to aid visibility of the beads and bead removal.  The beads were attracted 
1 cm from the 5 mm outer diameter magnet and 1.5 cm from the 12.7 mm outer diameter 
magnet. 
 
Figure 5.17: Magnetic bead mobility test. 
 
5.5 Validation of Dialysis Tube in Static Culture  
  
 The dialysis tube is an essential part of the design that separates the central flow of clean 
media of the bioreactor from the external media flow. Also, part of the design is to have a 
removable product and that is why it is essential that the cells would not be able to attach 
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themselves to the dialysis.  In order to test these parameters, a three centimeter piece of 16 mm 
diameter, 14,000 Da molecular weight cut-off, cellulose dialysis tubing (Ward’s Natural Science) 
was placed in P-150 Petri Dish with 20ml of growth media (DMEM with 10% FBS, 1% Pen-
Strep, 1% Glutamine, 1% NEAA, and 1% Sodium Pyruvate).  There were 6 x 106 cells seeded 
directly on top of the dialysis tube and the dish was placed in the incubator to be cultured for five 
days.  Light microscopy showed that cells were indeed growing on the dish, while an image from 
an inverted microscope, shown in Figure 5.19A, shows no cell growth on the dialysis tube.  In 
Figure 5.19B we are able to see a dialysis tube which was not exposed to cells. The lines in B are 
scratches on the surface of the dialysis tube. These results showed that surrounding cells were 
unaffected by the dialysis tube and that no cell were able to adhere to it. 
 
 
Figure 5.18: Dialysis tube viewed with 200X magnification. 
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5.6 Validation of Bioreactors Central Rod in a Static Culture 
 
  The central rod of the bioreactor (as shown in Figure 5.19) is a primary element of the 
design. It attracts the beads with cells, acts as a barrier between the magnets and the cells, as well 
as between the internal flow and external.  A principle element that needs to be observed is 
whether the central rod could indeed attach beads onto it and allow for an ECM to form.  
 
Figure 5.19: Central rod of the bioreactor. 
   
 The central rod of the bioreactor was placed in a P60 Petri dish with 40 ml of media 
(DMEM with 10% FBS, 1% Pen-Strep, 1% Glutamine, 1% NEAA, and 1% Sodium Pyruvate). 
A cell bead mixture of 50,000 beads to 2 x 106 cells, which was cultured on a rotator inside an 
incubator for two hours, was pipetted directly onto the central rod. The rod was rotated four 
times during the pipetting of the beads, in order to promote even distribution of cells and beads 
around the rod. The Petri dish was placed in the incubator to culture for five days. Once the five 
days have passed, the dialysis tube was removed from the central rod and was placed in 
Formalin, a chemical used to fix cells, for two hours. Once fixation was complete, the dialysis 
tube was placed in 70% ethanol until it was processed to be cut into five micron slices. Once the 
slices were placed on a slide, they were stained with Hematoxylin and Eosin stain (H&E), 
Masson's Trichrome Stain, and Picrosirius Red Stain.       
Magnet 
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H&E stain uses the basic dye hematoxylin, which colors basophilic structures with blue-
purple hue, and alcohol-based acidic eosin Y, which colors eosinophilic structures bright pink. 
The basophilic structures are ones containing nucleic acids, while eosinophilic structures are 
ones with extracellular protein (Laboratories 2007).  Masson's Trichrome Stain is a three colored 
stain were red represents keratin and muscle fibers, blue or green represents collagen and bone, 
light red or pink represents cytoplasm, and dark brown to black represents cell nuclei (Dako 
2010).  Picrosirius Red Stain is used to stain collagen I and III and is viewed as a red color 
(PolySciences 2009).  All the stains which have been described will show the structure of the 
ECM and indicate what morphological and chemicals structures are present. Unfortunately, no 
tissue formation was found in the H&E stain. 
5.7 Microbead Seeding Estimation 
The volume of agarose beads required to seed the magnetic tube of the bioreactor was 
estimated. This was accomplished through calculating the surface area of the magnetic tube and 
dividing this by the area of a bead.  This calculation was based on the assumption that the 
average bead size is 100 µm and that a layering the tube with a single layer of beads would be 
sufficient to culture a tissue.  The surface area of the effective tissue culture tube (distance along 
the two magnets) was divided by the cross-sectional area of a bead.  The bioreactor would 
require 279,680 beads to operate or .28 ml of settled beads.  However, it was specified that a 
minimum of 2 X 106 could be seeded at one time.  It is also likely that a minimum number of 
cells are required to form a confluent tissue.  Based on the cell-bead attachment experiment 
described in Chapter 5.3, approximately 4 cells attach per bead so a minimum of 500,000 beads 
(.5 ml) would be necessary.  While experimentation could be conducted to determine the optimal 
volume of beads, initial trials of the bioreactor could contain up to 2ml of beads in order to 
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assure a sufficient number of cells are seeded for further validation experiments.  Complete bead 
quantity calculations are shown in Appendix F.  
Chapter 6 Discussion 
 
 
The following chapter will discuss and evaluate the design decisions and applicability of 
the validation experiments.  It is important to discuss these various aspects in order to understand 
why the bioreactor was built in the way it was utilizing the various materials involved in the 
process. The various ramifications of the design were also explored from a variety of viewpoints.   
 
6.1 Bioreactor Design  
 
The fabrication of the bioreactor required simple machining that took four hours to 
perform and required two hours to assemble. The time required to machine the device could be 
minimized if a professional machinist would have been used.   The cost of building the device 
was less than $80, due to being comprised of commonly found lab items, but it is also important 
to note that many of the materials that were ordered for the device, such as the nylon rod, hex 
nuts and washers, had to be ordered in bulk because they are not sold separately.  
6.2 Bioreactor Materials Choice  
 
The materials which were picked for the development of the device were chosen for 
several reasons. It was important to choose materials that were biocompatible and would not 
leach any harmful toxins or chemicals into the bioreactor during use. Another consideration was 
the price of each material, considering our limited budget of $468 and the availability of each 
item. The 50N nickel-coated neodymium magnets, nylon thread, nylon hex nuts, nylon washers, 
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polystyrene conical tube, polystyrene pipette tip, cellulose dialysis tubing, and silicone tubing 
were all purchased for the price of $59.12. The manufacturing and assembly cost associated with 
working these materials was $0, while the cost of running each experiment was $24.40 
(calculations seen in Experimental Cost supplement).  The incorporation of these costs yielded a 
final cost of $336.71.  
6.3 Magnetic Beads  
 
The bead fabrication process required three days and approximately 8 hours of laboratory 
work.  The cost of materials for a yield of approximately 2 ml of beads was $24.17.  The bead 
validation experiments suggest that collagen-coated agarose microbeads can be effective cell 
carriers and can be positioned by permanent magnets.  By counting attached cells under a phase 
contrast microscope, we were able to approximate an average of 3.3 cells attached per bead.  
Collagen staining of the beads suggested that the coating process could use improvement 
because some of the beads had collagen attached while a number of beads did not stain positive 
for collagen.  This collagen coating is likely the limiting factor in cell attachment because cells 
typically cannot attach to agarose (Sakai, Hashimoto and Kawakami 2007).  It is possible that the 
surface of the beads did not get activated properly, thus the collagen could not bind.   
Commercially available magnetic agarose beads (75-150 μm diameter, carboxymethyl 
activated) were purchased from the BioScience Bead Division of CSS Inc. for $7 per ml.  The 
collagen coating process was repeated on the commercially available agarose magnetic beads 
and yielded a more robust result.  However, the surface of the beads did not appear to be 
uniformly coated in collagen which limits cell binding sites.  Time constraints did not permit 
repeating the cell attachment validation study with the commercial beads. 
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6.4 Flow Paths 
 
The media flow paths of the device were a key element of the design, because they may 
allow for nutrient flow to diffuse to both the center and the outside of the formed tissue.  Media 
flow rates for the central rod and outer housing were 8 ml/min. and 23 mL/min., respectively. 
Such flow should maximize diffusion of growth media to cells and potentially prevent cell death 
within the center tissue.  The addition of the dialysis tube may also allow the tissue to culture 
under conditions more closely resembling in vivo due to the increased surface area exposed to 
nutrients.  Another purpose of the dialysis tube other than acting as a semi-permeable barrier 
between the central flow path and external flow path is its capability of preventing the cells and 
beads from contacting the magnets at the center. This allows for simplified removal of the final 
tissue through removal of the dialysis tube. The two tests were performed to validate that the two 
separate flow paths could co-exist while the dialysis tube allowed easy removal of the beads 
from the magnet.  
  
6.5 Economic Impact  
 
If the bioreactor was able to successfully produce 3-D tissues that were approved for 
clinical usage by the FDA, it would be a giant leap in tissue engineering. The development of 
such a tissue would eliminate the need for autologous vessels and synthetic grafts. Also, the 
development of such a tissue would inspire the tissue engineering community to try and use this 
method to develop other organs, potentially eliminating the need for organ donors. The potential 
cost that would go into creating such tissues would be counterbalanced by the drugs needed to 
accommodate autologous vessels, synthetic grafts, and organs which were donated. Also, the 
cost that are associated with complications that might occur as a result of using autologous 
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vessels, synthetic grafts, and organs which were donated, would also counterbalance the cost 
associated with harvesting of cells need to grow the tissue in the bioreactor. Another potential 
application of this device is in research, were the tissue formation could be used to do bench top 
testing of drugs. The cost of developing the tissue would be outweighed by the costs needed to 
maintain animal models, potentially eliminating the need for food, shelter, and permits to test on 
the animals.   
  
6.6 Environmental Impact  
 
The development of the device was based on commonly used laboratory equipment, 
described in detail in Chapter Four. The usage of these materials would not require any special 
development of any parts of the device, but only gathering of materials from outside venders. 
This would decrease the amount of machining needed to create the device and decrease the 
amount of energy needed to develop it. Also, if the device was to be implemented into a 
commercial phase, the only environmental implication of the device would be its sterilization, 
which would have to be done using ethylene oxide.   
  
6.7 Societal Influence  
 
The capability to grow a cardiovascular graft would aid a large portion of society, 
allowing them to donate their cells to replace vessels in their own bodies. A successful 
development of such a tissue would be a huge help in the treatment of arteriosclerosis, 
thrombosis, and various trauma incidents involving damage to vascular tissue (Hoenig et al. 
2005). Heart bypass surgeries would no longer require secondary wound sites and removal of a 
vein in order complete the procedure, as well as being more readily available to patients without 
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the worry of donor-rejection or disease transfer that may be common with current transplants 
(Susa et al. 2009). 
6.8 Political Ramifications   
 
With the current usage of rat aortic smooth muscle cells in the development of tubular 
cell tissue, no political ramifications can be seen. However, the creation of a device that could 
produce a 3-D tissue may lead to the pursuit of the using stem cells to culture tissue. Though 
there is an ongoing political and ethical debate over the morality of the use of stem cells (which 
is outside the scope of this paper), the bioreactor does not need to specifically use these types of 
cells, and it is believed that the device itself would not cause political ramifications.  
6.9 Ethical Concerns  
 
As tissue engineering progresses, ethical issues and concerns rise. The potential to save 
lives may be looked at favorably when it comes with the development of blood vessel grafts. 
However, the device could be used to pursue research with stem cells, which would raise ethical 
concerns. The issue of whether life begins at the formation of cells or at birth is both an ethical, 
religious, and political debate that has surrounded stem cell research ever since its discovery  
(Edwards, Gearhart and Wallach 2000). Though there is an ongoing political and ethical debate 
over the morality of the use of stem cells (which is outside the scope of this paper), the 
bioreactor does not need to specifically use these types of cells.  The ethical concern of the usage 
of the device are minimal, when excluding stem cells, and lays the ethical responsibilities on the 
user which chooses the cell which are going to be used in the device.  
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Chapter 7 Final Design and Validation 
 
7.1 Materials for Bioreactor Fabrication 
  
 Several types of materials were used in the final design of our bioreactor. Such materials 
include nylon hex nuts, nylon washers and a nylon threaded rod, rare earth magnets, a conical 
tub, two 25ml pipette ends, and rubber stoppers (a complete list of materials can be found in 
Appendix D). These materials were each specifically picked for our design in order to meet our 
design objectives and budget constraints.  
 Materials such as the peristaltic pump, pipettes and conical tubes were supplied by the 
Biomedical Engineering Department at WPI and used in validating the design. The serological 
pipettes and conical tubes were used and cut for the purposes of our bioreactor. The dimensions 
are demonstrated in our final CAD drawing seen in Figure 4.11. 
 The nylon thread and screws were both chosen to accommodate the inner diameter of 
25ml pipette ends and a 50ml conical tub, as well as for price and material 
(http://www.usplastic.com/). Nylon is an inert material that is non-toxic and can withstand the 
potentially corrosive environment of the bioreactor. The usage of a nylon threaded rod 
eliminated the need to pre-treat the rod to resist cell or biomolecule adhesion.  Also, using this 
rod allowed the magnets to be secured through the usage of nylon hex nuts on either end. The 
inner diameter of the rod was chosen based upon the size of the available pipette ends, which 
was 1.5 cm. Nylon being a relatively inexpensive material that costs $4.60, made it an ideal 
choice for the inner threaded rod.  
 The magnets we chose for our design were nickel neodymium rare earth magnets 
(http://www.kjmagnetics.com/). We chose these particular magnets based on their magnetic 
strength and dimensions as well as price. These magnets have a strength that was noted as N52 
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which gives some indication as to the magnetic strength and therefore magnetic field the magnets 
would produce. N refers to the type of material the magnet was made from, neodymium, and the 
52 represents the grade of material used in the magnet. The grade of material correlates to the 
strength of the magnetic field produced, ranging from N42-N52 with 52 being the highest 
possible strength (http://www.kjmagnetics.com/neomaginfo.asp). Since the magnets needed to fit 
on the nylon rod, we chose magnets that had an inner diameter of 0.635 cm like that of the rod 
and an outer diameter of 1.2 cm. 
Silicon tubing was also purchased in order to connect the media chambers, bioreactor, and 
pump together. Silicon tubing was chosen since it allows carbon dioxide exchange through the 
bioreactor as well as being inexpensive and readily available. An inner diameter of 1.58 mm was 
purchased for the inner rod and 3.17 mm was used since it was available for free through the 
Worcester Polytechnic Biomedical Engineering department. Since it was desired to have a 
slower flow in the central rod, the variation in diameter would not have a negative effect on the 
bioreactor. 
7.2 Bioreactor Assembly  
Assembly 
The materials listed in Appendix D were used to assemble the final bioreactor. Parts such 
as the nylon rod, conical (polypropylene) tube, and 25 ml serological pipette ends were cut to the 
specified lengths of our design (as seen in both Figure 4.11 and Appendix E). Two holes (12.7 
mm in diameter) were drilled into the rubber stoppers in order to allow for the two flow systems 
in the final design. For one rubber stopper, a hole was placed in the center of the rubber stopper 
for flow to the inner rod of the bioreactor (12.7 mm in diameter) while the other was placed 
approximately 2-5 mm above the center hole to allow for outer fluid flow (8.38 mm in diameter), 
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as shown in Figure 7.1A. For the other rubber stopper, an additional hole (8.38 mm in diameter) 
was drilled into the rubber stopper on the opposite side in order to install a port for seeding beads 
into the bioreactor, as seen in Figure 7.1B.  
  
Figure 7.1: Rubber stoppers for bioreactor proof-of-concept. 
 
The magnet array (as determined from the magnetic field validation test) in the inner rod 
of the bioreactor was constructed by positioning the magnets on the center of the threaded nylon 
rod and securing them in place with nylon nuts.  Figure 7.2 shows the materials used in the 
construction of the inner rod (left) and the magnetic array secured on the threaded nylon rod 
(right).  
 
Figure 7.2: Magnetic rod assembly. 
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The magnets are N52 grade and composed of nickel plated neodymium.  In order to 
prevent nickel corrosion and the release of potentially toxic ions, the magnets could be coated 
with a hydrophobic silicone layer using Sigmacote (Sigma-Aldrich) but this was not applied to 
the bioreactor proof-of-concept. An additional nylon nut was placed on each end of nylon thread 
in order to secure a serological pipette end which was place over the end of the rod as shown in 
Figure 7.3 (left). The entire rod was then enclosed with 16 mm diameter (14,000 Da MW cutoff) 
dialysis tubing that was zip tied at the ends of the rod, as can be seen in Figure 7.3 (right).   The 
central rod construction was placed in a polypropylene tube and enclosed with two rubber 
stoppers, as shown in Figure 7.4. 
 
Figure 7.3: Dialysis tubing attachment to magnetic rod. 
 
 
 
 
Figure 7.4: Assembled bioreactor. 
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Tubing was connected into the holes drilled into the rubber stoppers to allow for fluid 
flow and silicon sealant was used to prevent fluid leakage from the rubber stoppers. The 
bioreactor was then connected to a multichannel pump and media reservoirs with CO2 permeable 
silicone tubing. The length of the tubing (a total of 20 ft) was used in order to connect the 
bioreactor to the media reservoirs within the incubator and the pump which was located external 
to the incubator. Figure 7.5 shows the fully constructed bioreactor with pump and media 
reservoirs. 
 
Figure 7.5: Bioreactor setup. 
Sterilization  
Prior to testing the bioreactor, all materials were cleaned with 70% ethanol and placed in 
the sterile hood.  A 70% ethanol solution was circulated through the bioreactor, tubing and media 
boxes. Following the ethanol, two PBS washes where passed through the bioreactor, tubing and 
media boxes to assure that no ethanol was remaining. Although this procedure is not considered 
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a sterilization technique, this procedure was satisfactory to prepare the device for cell culture. 
Antibiotics in the cell culture media also aided in the prevention of contamination.   
7.3 Fluid Flow Testing 
 After full assembly of the bioreactor, the flow system needed to be tested in order to 
determine the flow path of fluid through the bioreactor, if the bioreactor would leak, and if there 
are two distinct media flows from the inner tube and the outer tube.  
In order to test the flow system, an experiment was set up that would flow clear water 
through the outer tubing and green food-colored water through the center tube. Since the dialysis 
tubing used in the design of the project has such a small pore size, no food-colored water 
diffused from the inner tube to the outer tube. This allowed visible conformation that there were 
two distinct fluid systems. Figure 7.6 displays the initial set up of the system prior to the addition 
of green dye. Tubing was connected from the water beakers, through the peristaltic pump which 
compressed the tubing to generate a flow of determined to be about 8 ml/min for the inner flow 
and about 23 ml/min for the outer flow. Tubing then went from the exit of the bioreactor back 
into the beakers of water.  
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Figure 7.6: Bioreactor setup for fluid flow validation. 
 
In order to determine the fluid flow rate, specifications of the peristaltic pump were 
needed. Using the Dynamax user guide by Rainin, found in Appendix F, calculations of the fluid 
could be based on the type of tubing, length of tubing, and the inner diameter. Using the 
calculated table provided by the user guide, the flow was determined to be about 8 mL/min for 
the inner flow, with a tubing diameter of 1.58 mm, and about 23 mL/min for the outer flow, with 
a tubing diameter of 3.17 mm (Appendix F). These flow rates were close to the desired flow 
rates needed for the bioreactor.  
 Figure 7.7 shows the bioreactor running with a distinct flow of green water through the 
center of the tube with no leaks into the outer tubing. This test shows that no leaks occurred on 
the outer part of the bioreactor, as well as within the inner tube itself, which was the expected 
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result. The test provides a proof of concept and validation for the design of the bioreactor and 
shows that all the designed and manufactured parts work as intended.  
 
Figure 7.7: Bioreactor fluid flow validation. 
 
7.4 Bead Distribution Test 
Flow Based Distribution 
Test was conducted to see how fluid flow would affect bead distribution along the inner 
rod. The same setup as shown in Figure 7.7 was used.  A syringe was used to inject the beads 
into the tubing of the bioreactor.  After injecting beads into the tubing and reconnecting the 
bioreactor to the pump circulation, the pump was turned on. Figure 7.8 shows the results of the 
test and how the beads attracted to the rod. In the image, fluid is flowing from the left, into the 
bioreactor, and out on the right side of the picture. 
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Figure 7.8: Bead distribution with fluid flow. 
 
 Though beads spread over 3 cm of the rod, a large clump of beads, toward the left of the 
image, showed the team that a large majority of the beads were quickly attracted to the rod as a 
result of the magnetic field. Due to the relatively slow speed of fluid flow and the strong 
attraction of the magnetic field, the team determined that this was an ineffective way to achieve 
an even coating of beads along the length of the rod and another method would need to be 
considered.  
 It is also important to note that observations as to whether the outer diameter fluid flow 
would be able to displace beads after seeding them onto the inner tube was indirectly tested. The 
test showed little movement of the beads once they were attracted to the magnetic field and inner 
tube, suggesting that there was not enough shear force to displace the beads once placed into the 
bioreactor. 
Syringe Injection 
 Since the bead distribution due to fluid flow was not uniform, another method of 
injecting the beads through a syringe luer-lock was tested. By drilling an additional hole in one 
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Conical Tube 
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of the rubber stoppers, it would be possible to place a syringe luer-lock into it and allow injection 
of beads at a faster pace. This increased force that would allow the beads to spread more evenly 
over the rod and allow for a better bead distribution as compared to that obtained through the use 
of fluid flow. Using static flow, the bioreactor was filled with water in both the outer and inner 
tubes. Using a syringe, beads were injected on one end of the bioreactor and pushed into the 
bioreactor.  Figure 7.9 shows the results of the test and the distribution at which the beads settled. 
 
Figure 7.9: Bead distribution with syringe injection. 
 
There was some clumping closer to the injection site as seen in the flow distribution test, 
there are significantly more beads farther along the inner rod. The test demonstrated that beads 
were able to travel past the first initial field and magnetically attract to the rod farther down, 
which would ultimately make it more homogenous than that of the fluid distribution method. 
Also, the beads were able to attach themselves around the dialysis tube and it appeared that all 
injected beads did position themselves on the nylon rod. 
After taking the bioreactor apart, an attempt was made to move the beads along the 
magnets to see if there was resistance in the areas where there was a weaker magnetic field or if 
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the beads would stay in place. It was seen that the magnets did stick to any area along the inner 
rod that they were moved to. This result implies that though the beads were capable of sticking to 
any position on the inner rod, the strength of the magnetic field at certain positions made the 
beads more attractive to specific areas on the rod as a result of an incompletely homogeneous 
magnetic field.  
7.5 Tissue Culture 
Materials for Cell Culture 
Cell type and media choices were made based on availability and donations received 
from the Worcester Polytechnic Institute’s Biomedical Engineering Department. Rat smooth 
muscle cells were donated based on the cell type the design team chose to use as a model for 
their bioreactor. Media choice was then selected based on the necessities of the rat smooth 
muscle cells, which was also donated by the Biomedical Engineering Department. This media 
included nutrients, antibiotics biomolecules and pH indicators normally seen in laboratory 
media.  
Cell Bead Mixture 
As has been explained in Chapter 5, a defined quantity of cells is needed to be mixed in 
each Eppendorf of 50,000 beads. In order to quantify the amount of cells that were added, the 
“Initial Cell Count” assay was followed and can be found in Appendix F.  
The “Initial Cell Count” assay evaluated cells which were grown in a P-150 Petri dish. 
The cells were released from the Petri dish with 10mL Trypsin (Mediatech TRYPSIN EDTA 
0.25%) and after 4 minutes, 20mL normal growth media (DMEM with 10% FBS, 1% Pen-Strep, 
1% Glutamine, 1% NEAA, and 1% Sodium Pyruvate) was added. The cells were then 
centrifuged at 100g for 5 minutes and re-suspended with 20ml of media.  The cell suspension 
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was transferred into a microfuge tube that contained 40µL of Trypan Blue (Mediatech Trypan 
Blue 0.4% solution) solution. Afterwards, the cells were counted in a hemocytometer and the cell 
count yielded an average of 22 x 106 cells.  
Once a defined concentration of cells was found, 2 x 106 cells were added into each of the 
three Eppendorf of approximately 50,000 beads in each tube. The mixture was placed on a 
rotator inside an incubator for 2 hours, allowing them to attach as has been explained in Chapter 
5.      
Running of the Bioreactor 
Once the bioreactor, tubing and media boxes were sterilized in the hood, they were 
connected to each other. The media boxes were opened and filled with growth media 
accordingly; 70 ml was placed in the media box for the central flow and 80 ml was placed in the 
media box for the outer flow. The device (bioreactor, tubing and media boxes) was taken out of 
the sterile hood and was placed in the incubator. The tubing was connected to the RP-1 
Peristaltic Pump 9920-179 Rev E. The pump was turned on at a rate of 32rpm, producing 21 
ml/min. After letting the pump run for 5 minutes, the device was full of media and ready to have 
the cell bead mixture injected into it. The cell bead mixture was placed in the sterile hood and 
was taken up by a 5ml syringe. The syringe was connected to a capped 16 gauge needle and the 
cell bead mixture was injected into the bioreactor through an injector luer-lock, the luer-lock was 
wiped down with 70% ethanol prior to injection. The device was now ready to culture and was 
left in the incubator for 5 days.  
 
Removal of Tissue 
After 5 days of culture, the bioreactor was disconnected from all of its tubing and was 
taken out of the incubator. Once out of the incubator, the rubber stopper was taken off and the 
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dialysis tube was removed from the central rod. The dialysis tube was then placed in a 50 ml 
conical tube and submerged in Formaldehyde, a fixative chemical used to preserve cellular 
morphology, for two hours. Once fixation was complete, Formaldehyde was replaced with 70% 
ethanol, until it was ready to be processed and cut into five micron thick slices. Once the slices 
were placed on a slide, they were stained with Hematoxylin and Eosin stain (H&E), Masson's 
Trichrome Stain, and Picrosirius Red Stain. H&E stain uses the basic dye hematoxylin, which 
colors basophilic structures with blue-purple hue, and alcohol-based acidic eosin Y, which colors 
eosinophilic structures bright pink. The basophilic structures are ones containing nucleic acids, 
while eosinophilic structures are ones with extracellular protein (Laboratories 2007). Masson's 
Trichrome Stain is a three colored stain were red represents keratin and muscle fibers, blue or 
green represents collagen and bone, light red or pink represents cytoplasm, and dark brown to 
black represents cell nuclei (Dako 2010).  Picrosirius Red Stain is used to stain collagen I and III 
and is viewed as a red color (PolySciences 2009).  All the stains which have been described will 
show the structure of the ECM and indicate what morphological and chemicals structures are 
present. Protocols for each histology test can be found in Appendix E. 
Second Run of Bioreactor 
The histological stains that were performed of the dialysis tube, from the first run of the 
bioreactor, indicated that no tissue formation was present. The team suspected that the reason for 
the unsuccessful run was a low quantity of bead-cells mixture, not reaching the critical mass 
required to form a three-dimensional tissue. In order to correct this, the team decided to run the 
bioreactor once again and this team with 1.5 x 106 beads and 15 x 106 cells, trying to find the 
critical mass required to form a three-dimensional tissue, for a period of 7 days. Unfortunately, 
the bioreactor was suffering from a leakage which ended the run without any tissue formation.  
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Chapter 8 Conclusions and Future Work 
 
 The design team was successful in developing a magnetically seeded bioreactor for high 
density tissue cultures.  The principle objectives of the design were met and validated, though 
time constraints did not permit testing the bioreactors tissue growth capacity.  The final 
bioreactor has a number of possible applications including tissue engineering and bioprocessing.   
Bioreactor Design 
The novel design incorporates cells seeded on magnetic microparticles which are 
positioned by magnetic force and cultured on a semi-permeable membrane.  The membrane 
allows for diffusion to occur on both sides of the tissue and allows for enhanced sampling and 
monitoring with two media flow paths.  The central flow can provide clean media to the culture, 
aiding in nutrient diffusion and waste removal.  RASMC binding to the beads was confirmed and 
optimized.  Bead mobility and magnetic attachment was validated.  Bead distribution on the 
magnetic central tube was assessed with two loading methods.  Finally, the flow system was 
validated, the two flow paths do not mix and cells do not enter the clean flow of media.  While 
further engineering and optimization of the design is recommended, a functional proof-of-
concept was demonstrated. 
Future Work 
 There are a number of aspects of the final bioreactor design that can be improved with 
future study.  The bead distribution along the magnetic rod can be improved by adjusting the 
magnetic array and seeding method.  Computational modeling of the magnetic field can yield 
optimal magnet placement and polarization for a uniform magnetic field.  A smaller central rod 
can allow greater bead dispersion in the bioreactor and a more uniform distribution.  A smaller 
rod would increase the distance between the injection port where the beads are introduced and 
the magnets.  This would allow great bead dispersion within the reactor prior to their attraction to 
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the magnets.  Also the seeding method can be adjusted by installing ports on the side of the 
reactor for the introduction of beads (as shown in Figure 8.1).  Such ports were included in the 
design of the reactor but time constrains did not permit their incorporation into the proof-of-
concept.  The ports would allow for bead seeding at various locations along the nylon rod. 
 
Figure 8.1: Bioreactor with side ports. 
 
 Bead production and seeding protocols can be optimized to yield an improved collagen 
coating of the beads and increased cell seeding density.  A more robust collagen coating would 
provide more attachment sites for cells. Poly-lysine or Poly-lysine with collagen could be an 
alternative bead coating to improve cell attachment (Quirk et al. 2001, Yang et al. 2002, 
Srivastava, Gorham and Courtney 1990). Further study can be done to assess the optimal bead 
size for cell attachment.  Smaller beads would increase the effective binding surface area but 
changes in surface curvature may have an effect on cell attachment (Hogan, Degaetano and 
Klomparens 1991).    
 Further work could also involve quantification of nutrient diffusion through the dialysis 
membrane.  This would serve to validate the membranes efficiency and could be used to 
determine an optimal molecular weight cutoff for the membrane. 
Luer-lock port 
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Conclusion 
A proof-of-concept of the novel bioreactor design was assembled and validation testing 
was performed.  Bead positioning, cell seeding, and media flow design aspects were confirmed.  
The cell-free media flow through the central tube could improve nutrient diffusion to the culture.  
These design considerations would allow for the device to create a tubular tissue construct and 
culture it in conditions which resemble those found in vivo.  The bioreactor also has the potential 
for bioprocessing were a cell type which produces a product of interest can be seeded into the 
reactor and the product could be isolated through the dialysis membrane.  While a number of 
engineering improvements could be made to the multifaceted design, this magnetically seeded 
bioreactor system has significant potential to advance the field of three-dimensional cell culture.  
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Glossary 
 
 
Autologous – Derived from the same individual (Merriam-Webster Dictionary) 
Biocompatible – Compatibility with living tissue or a living system by not being toxic, injurious, 
or physiologically reactive and not causing immunological rejection (Merriam-Webster 
Dictionary) 
Bioprocessing – A method used to produce commercially useful biological material (science-
dictionary.com) 
Carboxyl groups – A carbon atom double-bonded to an oxygen and single-bonded to a hydroxyl 
group (Biochem.Northwestern.edu) 
Client Statement – The client’s general problem or request 
Design Space – Mental construct of intellectual space that envelops or incorporates all of the 
potential solutions to a design problem (Dym and Little 2004) 
Endothelial cells – Relating to, or produced from endothelium (Merriam-Webster Dictionary) 
Endothelium – An epithelium of mesoblastic origin composed of a single layer of thin flattened 
cells that lines internal body cavities (Merriam-Webster Dictionary) 
Extracellular Matrix (ECM) – Any substance produced by cells and excreted to the extracellular 
space within the tissues, serving as a scaffolding to hold tissues together and helping to 
determine their characteristics (medical-dictionary.thefreedictionary.com) 
Enzymatically – Relating to, or produced by an enzyme (Merriam-Webster Dictionary) 
Fermentation – A chemical change with effervescence (Merriam-Webster Dictionary) 
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Fibroblasts – A connective-tissue cell of mesenchymal origin that secretes proteins and 
especially molecular collagen from which the extracellular fibrillar matrix of connective tissue 
forms (Merriam-Webster Dictionary) 
Functions – The action for which a person or thing is specially fitted or used or for which a 
thing exists (Merriam-Webster Dictionary) 
Growth Media – See Media 
Hepatocytes – A liver cell (medical-dictionary.thefreedictionary.com) 
Homogenous – Uniform structure or composition throughout (Merriam-Webster Dictionary) 
Hypoxia – A deficiency of oxygen reaching the tissues of the body (Merriam-Webster 
Dictionary) 
In vitro – Outside the living body and in an artificial environment (Merriam-Webster Dictionary) 
In vivo – In the living body of a plant or animal (Merriam-Webster Dictionary) 
Keratinocytes – An epidermal cell that produces keratin (Merriam-Webster Dictionary) 
Ligand – A group, ion, or molecule coordinated to a central atom or molecule in a complex 
(Merriam-Webster Dictionary) 
Media – A nutrient system for the artificial cultivation of cells or organisms (Merriam-Webster 
Dictionary) 
Microcarriers – A microscopic particle to which something is attached (science-dictionary.com) 
Morphology – The form and structure of an organism or any of its parts (Merriam-Webster 
Dictionary) 
Nanoparticles – A microscopic particle whose size is measured in nanometers (Merriam-
Webster Dictionary) 
Necrosis – Localized death of living tissue (Merriam-Webster Dictionary) 
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Objective – Something toward which effort is directed: an aim, goal, or end of action (Merriam-
Webster Dictionary) 
Scaffolds – A support, either natural or artificial, that maintains tissue contour (medical-
dictionary.thefreedictionary.com) 
Smooth Muscle Cells – a type of muscle found in involuntary muscles (science-dictionary.com) 
Superparamagnetic –  A phenomenon by which magnetic materials may exhibit a behavior 
similar to paramagnetism even when at temperatures below the Curie or the Néel temperature. 
This is a small length-scale phenomenon, where the energy required to change the direction of 
the magnetic moment of a particle is comparable to the ambient thermal energy. At this point, the 
rate at which the particles will randomly reverse direction becomes significant (medical-
dictionary.thefreedictionary.com) 
Tissue Engineering – is the use of a combination of cells, engineering and materials methods, 
and suitable biochemical and physio-chemical factors to improve or replace biological functions. 
While most definitions of tissue engineering cover a broad range of applications, in practice the 
term is closely associated with applications that repair or replace portions of or whole tissues 
(i.e., bone, cartilage, blood vessels, bladder, etc...). Often, the tissues involved require certain 
mechanical and structural properties for proper function. The term has also been applied to 
efforts to perform specific biochemical functions using cells within an artificially-created support 
system (e.g. an artificial pancreas, or a bioartificial liver). The term regenerative medicine is 
often used synonymously with tissue engineering, although those involved in regenerative 
medicine place more emphasis on the use of stem cells to produce tissues (medical-
dictionary.thefreedictionary.com) 
 
  
Appendix A: Gantt Chart 
 
 Nov  Dec   Jan    Feb    Mar     Apr  
Tasks 20 27 4 11 18 8 15 22 29 5 12 19 28 5 12 17 24 31 7 14 
                     
MQP                     
Design (CAD)                      
Purchase parts                       
Workshop: Fabrication                        
Assembly                      
Test and run with cells                         
Beads                     
Estimate total number of 
beads                 
      
Make beads with 
"collagen"                 
      
Magnet                     
Magnet array                       
Media                     
Purchase correct media 
for SMC                 
      
Fluidics                     
Flow rate calculation                       
Sterile sampling                         
Removing tissue                        
Dialysis flow validation                         
Assay                     
Monitoring and feedback (pH, 
etc.)                  
      
# Cells                         
ECM                        
Red: AK, Blue: AC, Green: YH, Black: All 
Appendix B: Pair-wise Comparison Chart 
 
 3D Tissue Seeding of 
multiple cell 
types  
 
Efficiency in cell 
positioning 
 
Ease of 
sampling 
 
Ease of 
Manufacturing 
 
Value Total 
3D Tissue X 1 1 1 1 4 
Seeding of 
multiple cell types  
0 X 0 0 1 1 
Efficiency in cell 
positioning 
0 1 X 0 1 2 
Ease of sampling 0 1 0 X 1 2 
Ease of 
Manufacturing 
 
0 0 0 0 X 0 
  
Appendix C: Decision Matrices 
 
Type of Magnetic Array 
Decision Matrix Magnetic rod External magnet 
with dialysis 
tube 
Internal 
magnet dialysis 
tube 
Halbach 
array 
Objectives:     
Three dimensional tissue 2 2 2 2 
Seeding of multiple cell 
types 
2 2 2 0 
Efficiency of cell 
positioning 
2 1 2 0 
Ease of sampling 1 1 2 1 
Ease of manufacturing 2 2 1 1 
     
Functions:     
Uniform cell seeding 1 2 1 2 
Optimal nutrient transport 
for cell growth 
1 2 2 2 
Tubular tissue construct 0 2 2 0 
Removable product 1 1 2 2 
Monitoring (pH, CO2, temp) 0 1 2 1 
     
Constraints:     
Cost 2 1 1 1 
Time 2 2 1 1 
Fits in an incubator 2 2 2 1 
Sterilizable 1 2 2 2 
Scaffold-free 2 2 2 2 
     
Total 21 25 26 18 
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Bead Seeding Method 
Decision Matrix Syringe 
injection 
Manually rolling 
magnet 
Automated 
rolling 
Flow 
Assisted 
Objectives:     
Three dimensional tissue 2 2 2 2 
Seeding of multiple cell 
types 
2 1 1 2 
Efficiency of cell 
positioning 
2 2 1 1 
Ease of sampling 2 2 2 2 
Ease of manufacturing 1 1 1 2 
     
Functions:     
Uniform cell seeding 2 2 1 1 
Optimal nutrient transport 
for cell growth 
    
Tubular tissue construct 2 2 2 1 
Removable product 2 2 2 2 
Monitoring (pH, CO2, 
temp) 
2 2 2 2 
     
Constraints:     
Cost 1 2 1 2 
Time 2 1 1 2 
Fits in an incubator 2 2 2 2 
Sterilizable 2 1 1 2 
Scaffold-free 2 2 2 2 
     
Total 26 24 21 25 
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Flow System 
Decision Matrix Single 
Reservoir 
Dual reservoir Semi-
permeable 
membrane split 
Objectives:    
Three dimensional tissue 2 2 2 
Seeding of multiple cell 
types 
2 2 2 
Efficiency of cell positioning 2 2 2 
Ease of sampling 1 2 2 
Ease of manufacturing 2 1 0 
    
Functions:    
Uniform cell seeding 2 2 2 
Optimal nutrient transport 
for cell growth 
1 2 2 
Tubular tissue construct 2 2 2 
Removable product 2 2 2 
Monitoring (pH, CO2, temp) 1 2 1 
    
Constraints:    
Cost 2 1 1 
Time 2 2 1 
Fits in an incubator 2 1 1 
Sterilizable 2 2 1 
Scaffold-free 2 2 2 
    
Total 27 29 25 
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Appendix D: List of Materials for Final Bioreactor Design 
 
Materials: 
1 conical tube (98.43 mm length, 28.57 mm outer diameter, 25.4 mm inner diameter) 
2 rubber stoppers (19.05 mm bottom diameter, 25.4 inch upper diameter, 12.7 mm thickness) 
6.35 mm diameter threaded nylon rod  
(2) N52 Cylindrical ring magnets (12.7 mm length, 12.7 mm outer diameter, 6.35 mm inner 
diameter) 
2 nylon washers (6.35 mm diameter) 
6 nylon hex nuts (6.35 mm diameter) 
50.8 mm x 101.6 mm Dialysis tubing section  
2 pipette tip ends (25 ml size) (44.45 mm length, 15.87 mm outer diameter, 14. 28 mm inner 
diameter) 
2 plastic zip ties 
Appendix E: Protocols 
Assembly of Bioreactor 
Nylon Threaded Rod Fabrication Protocol 
Materials: 
1. 6.35 mm diameter threaded nylon rod 
2. (2) N52 Cylindrical ring magnets (12.7 mm length, 12.7 mm outer diameter, 6.35 mm 
inner diameter) 
3. 2 nylon washers (6.35 mm diameter) 
4. 6 nylon hex nuts ends (6.35 mm diameter) 
5. 2 in x 4 in Dialysis tubing  
6. 2 pipette tip ends (25 ml) 
7. 2 plastic zip ties 
Protocol: 
1. Mark out thread into 76.2 mm piece ( length determined by CAD drawing) 
2. Mark out position of magnets- 
• In length each magnet+ two hex nut group is 25.4 mm long (6.35 mm hex nut + 12.7 mm 
magnet + 6.35 mm hex nut) 
• Length between hex nuts is equal to two magnet lengths apart in order to achieve an 
evenly distributed magnetic field 
o 25.4 mm apart 
• Length between last hex nut and end of rod should be even on both sides 
o 19.05 mm apart 
 
3. Assemble magnets onto rod 
4. Add pipette tip ends to either side of the nylon thread 
• Add two nylon hex nuts at the end of the nylon thread for securing the pipette tip ends 
5. Wrap the dialysis tubing around the nylon thread 
• Leave slight give for fluid glow through inner thread 
6. Secure on pipette ends and dialysis tubing using plastic zip ties 
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Outer Bioreactor Fabrication Protocol 
 
Materials: 
1. Nylon Threaded Rod (assembled with magnets) 
2. 1 conical tube (98.43 in length, 28.57 in outer diameter, 25.4 mm inner diameter) 
3. 2 rubber stoppers (19.05 mm bottom diameter, 25.4 mm upper diameter, 12.7 mm 
thickness) 
Protocol:  
1. Drill 2 holes ( 12.7 mm in diameter) in rubber stoppers 
o One in center, one 6.35 mm above (for media flow of inner and outer chamber 
of bioreactor) 
2. Place 1 end of nylon thread (pipette end) inside the rubber stopper. 
3. Fit rubber stopper and nylon tube into conical tubing end 
4. Follow sterilization protocol (see Bioreactor Running and Sterilization) 
 
Homogeneous Magnetic Field Analysis 
 
Materials: 
1. 2 N52 neodymium rare earth magnets 
2. 1 nylon washer 
3. 1 nylon hex nut 
4. Magnetic Paper (Made by Millipore) 
5. 76.2 mm bar magnet (polarized on each end) 
6. Camera 
 
Procedure: 
1. Assemble magnets together with nylon hex nut in between the two magnets. Attractive 
forces between the magnets hold them together. 
2. Take photo of assembly 
3. Lay Magnetic Paper over the magnetic array. 
4. Photograph changes in magnetic paper. 
5. Clear magnetic paper using bar magnet by wiping the bar magnet over the magnetic 
paper till the paper appears completely green again. 
6. Repeat steps 1-5 using a nylon washer in place of the nylon hex nut. 
7. Repeat steps 1-5 using nothing between the two magnets. 
Diffusion Validation of Inner Rod 
 
Materials: 
1. Assembled bioreactor (Nylon Threaded Rod inside conical tubing, closed with stoppers) 
2. Tubing connection on one side of the bioreactor (center hole only) 
3. 2 plugs 
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4. Liquid Syringe (100 mL) 
5. Food Coloring Dye (Light and Dark) 
6. About 120 mL water 
Protocol: 
1. Fill the outer bioreactor with light colored Food Coloring and Water. 
2. Place end of tubing connectors in bucket or sink receptor 
3. Plug the outer bioreactor connectors closed. 
4. Flow dark food coloring water into center Nylon Threaded Rod using liquid syringe. 
5. Record and photograph diffusion of dark colored dye into light colored dye (if any) 
 
Growth Media Preparation  
 
DMEM with 10% FBS, 1% Pen-Strep, 1% Glutamine, 1% NEAA, and 1% Sodium 
Pyruvate) 
 
Materials: 
1. 500mL DMEM (1 bottle; Mediatech 15-017-CV) 
2. 50mL Fetal Bovine Serum (FBS; PAA A15-201, Lot A20107-7003) 
3. 5mL Penicillin-Streptomycin (P/S; Mediatech 30-002-CI) 
4. 5mL Glutamine (Glut; Mediatech 25-015-CI) 
5. 5mL MEM non-essential amino acid (NEAA; Mediatech 25-025-CI) 
6. 5mL Sodium Pyruvate (sod. Pyruv; Mediatech 25-000-CI) 
Procedure: 
1. Heat DMEM and thaw aliquots of FBS, P/S, Glut, NEAA, and sod. Pyruv. in 37°C water 
bath 
2. Add all aliquots to DMEM 
3. Label bottle with contents, initials, and date 
Note: 
If making media in glass media bottle pour through a sterile bottle-top filter before 
adding to sterile bottle. 
Rat Smooth Muscle Cell (RAMSC) Culture 
 
All cell manipulation was done in a sterile hood using meticulous aseptic technique.  
Media was pre-wormed to 37°C in water bath and confirmed that phenol red indicator 
dye in media and culture is an appropriate color (Yellow 6.5, Orange 7.0, Red 7.4, Pink 
7.6). Cells were grown in a P-150 Petri dish with 20ml of growth media.  Growth media 
was changed every 2-3 days and cell yields were an average of 8.8 x 106 cells. The cells 
were incubated in 37°C, 5%CO2 humidified Incubator. 
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Cell Quantification 
 
In order to evaluate the quantity of cells that are needed to create a three-dimensional 
tissue, a few assays need to be performed. The first assay “Prior to Loading” will 
evaluate the quantity of cells that are being loaded into the bioreactor, while the “24 
Hours Post Loading” assay will assess the quantity of cells which have not attached 
themselves to the dialysis tube. The last assay “Post Tissue Formation” (on the next 
page) will estimate the quantity of cells which exist in the entirety of the tissue formed.   
Prior to Loading  
 
All cell manipulation should be done in a sterile hood using meticulous aseptic 
technique.  Spray all surfaces with 70% ethanol to avoid contamination.   
 
Materials: 
1. Two 5mL sterile pipette tips 
2. Three 10mL sterile pipette tips 
3. 100 µL pipette tip box 
4. Pasture pipette tips (sterile) 
5. 15mL tube 
6. Trypan Blue 
7. Media (DMEM WITH 10% FBS, 1% PEN-STREP, 1% GLUTAMINE, 1% NEAA, AND 1% 
SODIUM PYRUVATE)   
8. Trypsin 
9. Hemocytometer 
10. One Microfuge tube 
 
Protocol: 
1. Media should be pre-wormed to 37°C in water bath. Confirm that phenol red indicator 
dye in media and culture is an appropriate color (Yellow 6.5, Orange 7.0, Red 7.4, Pink 
7.6) 
2. Clean all materials with 70% ethanol and place in hood 
3. Open P-150 Petri dish which is containing cells  
4. Without touching the wall that the cells are adhered to, remove and dispose of growth 
media using Pasture pipette tip 
5. Add 10mL Trypsin  
6. After 4 minutes add 20 mL normal growth media (The FBS will inactivate the residual 
Trypsin) 
7. Pipette cells up and down until it is released from the flask.   
8. Remove cell mixture from flask and place in a 15mL conical tube 
9. Centrifuge 50 mL tube at 100g for 5minutes 
10. Remove supernatant using Pasture pipette tip 
11. Suspend cell pellet with 20 ml of media   
12. Transfer 40 µL of cell suspension to a microfuge tube 
13.  Add 40 µL of Trypan Blue solution (dilution factor =2) 
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14. Apply 20 µL of suspension to both chambers of hemocytometer by gently touching 
pipette tip to lower edge of overlying cover slip. 
15. Count cells within 1 mm2 center square (5xS grid) of both chambers. Viable cells will be 
clear and non-viable cells will stain blue. 
16. Cell counts can be calculated using the following formula: 
a. Average count per  1 mm2 square*dilution factor *104 =  # cells/ml 
17. Store media at 4°C between uses 
 
 
Bead Fabrication 
 
Protocol developed by Christopher Lambert’s lab at WPI.  Beads were prepared with the 
assistance of Anna Maziarz and Eftim Milkani. 
 
Magnetic Fluid 
 
Materials 
1. 600ml beaker 
2. 400ml beaker 
3. Overhead mixer wrapped in Teflon tape 
4. Water bath 
5. Iron(II) Chloride Tetrahydrate 98% 
6. Iron(III) Chloride Hexahydrate 97-102.0% 
7. Dodecanoic acid (Lauric acid) 98% 
8. Ammonia 
9. Magnet 
Protocol: 
1. Add 2 grams of lauric acid in 200ml of .12 M Iron (II) Chloride Tetrahydrate and .24 M 
Iron (III) Chloride hexahydrate to a 600ml beaker. 
2. Place beaker in 50 deg C water bath at stir with overhead mixer at 1300rpm. 
3. Add 40mL of 25% ammonia solution to the beaker using a pipette. 
4. Continue stirring at 1300rpm for 30 minutes while maintain the temperature of the 
water bath at 50 deg C. 
5. Place the beaker over a magnet and add .5% ammonia solution until the precipitate 
separates and decant the solution using a pipette. 
6. Transfer the precipitate to a 400ml beaker with 100ml of 1g/L lauric acid solution. 
7. Allow the solution to settle overnight and decant the clear liquid. 
Agarose bead preparation 
 
Materials 
1. Magnetic fluid 
2. Ammonia 
3. Soybean oil 
4. Polysorbate 80 
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5. Overhead mixer 
6. 400ml beaker 
7. 150ml beaker 
8. 50ml flask 
9. Agarose 
10. Acetone 
11. Water bath 
12. Sonicator 
13. Microwave 
14. 3ml syringe with 18G needle 
15. Ice 
16. Magnet 
 
Protocol 
1. Dilute 10ml of magnetic fluid in 10ml of DI water in a 50ml flask. 
2. Bring the diluted magnetic fluid to a pH of 7 by adding .5% ammonia solution. 
3. Sonicate the magnetic fluid for 30 minutes. 
4. Add 180ml of soybean oil and 5.4g polysorbate to a 400ml beaker. 
5. Place the beaker in a 90 deg C water bath and stir at 630rpm. 
6. Add 10ml of 3% agarose solution to a 150ml beaker and heat in a microwave for 50 
seconds. 
7. Place the beaker of agarose solution and flask of magnetic fluid in the water bath for 20 
seconds. 
8. Quickly add the agarose solution to the flask of magnetic fluid while shaking to facilitate 
mixing. 
9. Return the flask to the water bath and load the syringe with the solution. 
10. Using the syringe, transfer the solution drop-wise into the soybean oil mixture. 
11. After adding all of the magnetic fluid, stir for an additional 10 minutes at 90 deg C. 
12. Rapidly cool the water bath to 11 deg C by adding ice. 
13. Continue stirring for 20 minutes at 630rpm. 
14. Add acetone to the mixture until the oil phase turns clear and place the beaker over a 
magnet. 
15. Decant the solution and rinse beads with acetone. 
16. Rinse and decant the beads three times with DI water. 
17. Store the beads in DI water at 4 deg C. 
Bead Sterilization 
 
Materials 
1. Agarose beads 
2. Ethanol 
3. DI Water 
4. 40ml beaker 
Procedure 
1. Add the agarose beads to a 40 ml beaker. 
2. Add 70% Ethanol in DI water and let soak for 10 minutes. 
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3. Place the beaker over a magnet and decant the solution. 
4. Rinse the beads with DI water 3 times. 
Bead Activation 
 
Materials 
1. 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
2. N-Hydroxysuccinimide (NHS) 
3. DI Water 
4. Shaker 
5. Aluminum foil 
6. 10ml syringe with 2um filter 
7. 20ml beaker 
8. Sterile agarose beads 
Protocol 
1. Filter 5ml of .1M EDC with .02M NHS solution using the 2um syringe filter. 
2. Suspend the agarose beads in the EDC/NHS solution in a 20ml beaker and wrap in 
aluminum foil. 
3. Place on a shaker for 30 minutes at room temperature. 
4. Rinse the beads three times with DI water. 
Collagen coating 
 
Materials 
1. Sterilized and activated agarose beads 
2. Collagen 
3. Sodium carbonate 
4. Sodium bicarbonate 
5. Magnet 
6. PBS 
Protocol 
1. Combine .1M sodium carbonate with .1M sodium bicarbonate to form a 9.6pH buffer 
solution. 
2. Combine 1ul of collagen with 1ul of buffer solution. 
3. Store mixture at 4 deg C overnight. 
4. Rinse the beads with PBS three times and store in PBS solution. 
Bioreactor Tissue Culture Protocol 
 
All cell manipulation should be done in a sterile hood using meticulous aseptic 
technique.  Spray all surfaces with 70% ethanol to avoid contamination.   
 
Materials  
1. One P-150 Petri dish with cells  
2. Beads in 15ml conical tube 
3. Petri dish  
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4. Media (DMEM WITH 10%FBS, 1%PEN-STREP, 1%GLUTAMINE, 1%NEAA, AND 1%SODIUM 
PYRUVATE)  
5. Bioreactor 
6. Media Box 
7. Pump 
8. Tubing 
9. 70% Ethanol 
10. Sterile 1X PBS 
 
Protocol: 
 
Day 1 
1. Clean all materials with 70% ethanol and place in hood 
2. Follow the “Assembly of Bioreactor” protocol 
3. Clean bioreactor, media boxes, and tubing with 70% Ethanol  
4. Run 1X PBS through bioreactor, media boxes, and tubing. 
5. Repeat steps 2 and 3, twice  
6. Connect the bioreactor to media boxes using the tubing 
7. Fill each media box with 110ml of media 
8. Place bioreactor and media boxes in the incubator 
9. Run tubing through peristaltic pump 
10. Turn pump on and let the bioreactor fill with media 
11. Take out P-150 Petri with cells and follow the “Prior to Loading” assay 
12. Take 15 x 106 cells out of the 50ml conical tube and re-suspend them in 15ml conical 
tube which contains the beads. 
13. Expose cells to the beads for a period of 2 hours 
14. Sterilize injection port of the bioreactor (use 70% ethanol) 
15. Insert new mixture of beads and cells into the bioreactor through injection valves using 
a syringe. 
 
Removal of Tissue 
 
Materials  
1. Bioreactor 
2. Media Box 
3. Peristaltic pump 
4. Silicone tubing  
5. Formalin 
6. 70% Ethanol 
7. 50ml Conical tube 
 
Protocol: 
 
1. Clean all materials with 70% ethanol and place in hood 
2. Take device out of incubator and place in sterile hood 
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3. Take 50ml conical tube and fill it with Formalin 
4. Disconnect the bioreactor from the media box  
5. Without touching the dialysis tube that the cells are adhered to, remove growth media 
using a Pasture pipette tip 
6. Takeout threaded nylon rod 
7. Gently pull the newly formed tissue off the threaded nylon rod  
8. Place dialysis tube in the 50ml conical tube for a period of 1 hour 
9. After an hour, replace Formalin with 70% Ethanol 
Masson Trichrome Stain Procedure 
 
Histology testing and protocol was performed and written by Sharron Shaw 
 
Masson Trichrome 
Reagents: 
Bouin’s Solution (Sigma HT10-1-128) 
Weigert Iron Hematoxylin 
 Solution A (Sigma HT107-500ml) 
 Solution B (Sigma HT109-500ml) 
Working Solution: 
  Mix Equal parts of solutions A and B. 
Biebrich Scarlet-Acid Fuchsin Solution 
 1% Biebrich Scarlet 
  Biebrich Scarlet   2gm 
  Distilled water 200ml 
 1% Acid Fuchsin 
  Acid Fuchsin  1gm 
  Distilled Water  100ml 
 Working Solution: 
  1% Biebrich Scarlet 180ml 
  1% Acid Fuchsin  20ml 
  Glacial Acetic Acid 2ml 
Phosphomolybdic/Phosphotungstic Acid Solution 
 Working Solution: 
   Phosphomolybdic Acid Solution (HT153-250ml)  1 part 
   Phosphotungstic Acid Solution (HT152-250ml)  1 part 
   Distilled water      2 parts 
1% Aniline Blue Solution  
 Aniline Blue   5gm 
 Glacial Acetic Acid  4ml 
 Distilled Water   200ml 
1 % Acetic Acid Solution  
 Glacial acetic acid   1 mL 
Distilled Water   99mL 
Paraffin Procedure: 
1. Dehydrate in Xylene I for 3 minutes. 
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2. Dehydrate in Xylene II for 3 minutes. 
3. Dehydrate in Xylene III for 3 minutes. 
4. Dehydrate in 100% ETOH for 3 minutes. 
5. Dehydrate in 100% ETOH for 3 minutes. 
6. Dehydrate in 95% ETOH for 1 minute. 
7. Dehydrate in 70% ETOH for 1 minute. 
8. Rinse slides well in distilled water. 
9. Mordant the sections in Bouin solution for 1 hour at 56 C. 
10. Remove slides from oven, allow to cool, wash in running water until the yellow color 
disappears. 
11. Stain sections in Weigert hematoxylin for 10 minutes. 
12. Wash in warm running tap water for 10 minutes. 
13. Stain sections in Biebrich scarlet-acid fuchsin solution for 3 minutes. 
14. Rinse in distilled water. 
15. Place slides in Phosphomoybdic/Phosphotungstic acid solution for 15 minutes.  Discard 
this solution. 
16. Stain sections in aniline blue solution for 5 minutes. 
17. Rinse slides in distilled water. 
18. Place slides in 1% acetic acid solution for 5 minutes. Discard this solution. 
19. Rinse in several changes of tap water. 
20. Dehydrate through graded alcohols, clear in two changes of xylene and mount with 
cytoseal. 
 
Results: 
Nuclei      Black 
Cytoplasm, Keratin, Muscle fibers  Red 
Collagen and Mucus    Blue 
 
Hematoxylin and Eosin Staining Procedure  
 
Histology testing and protocol was performed and written by Sharron Shaw 
 
Procedure 
1. Xylene----------------------------------------------------------------------3 Minutes 
2. Xylene----------------------------------------------------------------------3 Minutes 
3. Xylene----------------------------------------------------------------------3 Minutes 
4. 100% ETOH---------------------------------------------------------------3 Minutes 
5. 100% ETOH---------------------------------------------------------------3 Minutes 
6. 95% ETOH-----------------------------------------------------------------1 Minute 
7. 70% ETOH-----------------------------------------------------------------1 Minute 
8. Rinse in running H2O-----------------------------------------------------Until clear 
9. Harris Hematoxylin--------------------------------------------------------5 Minutes 
10. Rinse in running H2O----------------------------------------------------Until clear 
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11. Differentiate sections in 1% HCL mixed in 70% ETOH. -----------2-3 quick dips. 
             (.25 ml HCL to 100 ml of 70% ETOH) 
12. Rinse in running H2O----------------------------------------------------30 Seconds 
13. Blue sections in ammonia solution-------------------------------------1 Minute.  
            (3ml of 28% ammonia hydroxide in 1L tap water.) 
14. Rinse in running warm H2O--------------------------------------------5 Minutes 
15. 95% FTOH----------------------------------------------------------------30 seconds 
16. Counterstain in Eosin-Y-------------------------------------------------1 Minute 
17. 70% ETOH----------------------------------------------------------------30 Seconds 
18. 95% ETOH----------------------------------------------------------------30 Seconds 
19. 95% ETOH----------------------------------------------------------------30 Seconds 
20. 100% ETOH--------------------------------------------------------------1 Minute 
21. 100% ETOH--------------------------------------------------------------1 Minute 
22. 100 % ETOH-------------------------------------------------------------1 Minute 
23. Xylene---------------------------------------------------------------------1 Minute 
24. Xylene---------------------------------------------------------------------1 Minute 
25. Xylene---------------------------------------------------------------------1 Minute 
Coverslip slides using synthetic mounting medium. 
 
Results 
Nuclei-------------- Blue 
Cytoplasm----------Pink 
Blood----------------Red 
 Picrosirius Red Protocol 
 
Histology testing and protocol was performed and written by Sharron Shaw 
 
Reagents: 
0.1% Sirius Red Solution 
 Direct Red 80 (Aldrich 36,554-8)  0.25gm 
 Picric Acid (Sigma P6744-1GA)  250ml 
Procedure: 
1. Deparaffin in Xylene I clearing agent for 3 minutes. 
2. Deparaffin in Xylene II clearing agent for 3 minutes. 
3. Deparaffin in Xylene III clearing agent for 3 minutes. 
4. Hydrate in 100% ETOH for 3 minutes. 
5. Hydrate in 100% ETOH for 3 minutes. 
6. Hydrate in 95% ETOH for 1 minute. 
7. Hydrate in 95% ETOH for 3 minutes. 
8. Hydrate in 70% ETOH for 3 minutes. 
9. Rinse slides well in water. 
10. Place in Picrosirius solution for 30 minutes. 
11. Dehydrate in 80% ETOH for 1 minute. 
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12. Dehydrate in 95% ETOH for 1 minute. 
13. Dehydrate in 95% ETOH for 1 minute. 
14. Dehydrate in 100% ETOH for 5 minutes. 
15. Dehydrate in 100% ETOH for 5 minutes. 
16. Dehydrate in 100% ETOH for 10 minutes. 
17. Place in Xylene I clearing agent for 3 minutes. 
18. Place in Xylene II clearing agent for 3 minutes. 
19. Place in Xylene III clearing agent for 3 minutes. 
20. Mount with mounting media. 
 
Results: 
Collagenous fibers  Red 
Other tissue fibers  Green 
 
Appendix F: Calculations 
Bead Concentration Approximation 
 
Assuming average bead diameter of 100μm. 
  
1 cm3 = 1 ml 
 
Number of beads per cm3 = � 1𝑐𝑐𝑐𝑐
𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵  𝐵𝐵𝑑𝑑𝐵𝐵𝑐𝑐𝐵𝐵𝑑𝑑𝐵𝐵𝑑𝑑 �3= 1 × 106 beads/cm3 = 1 × 106 beads/ml 
 
Bead Seeding Calculations 
 
Dimensions of central rod: 16mm diameter, 43.7mm length 
Surface area of rod: 43.7(𝑐𝑐𝑐𝑐) 𝑋𝑋 16(𝑐𝑐𝑐𝑐) 𝑋𝑋 𝛱𝛱  
 
Assuming bead diameter of 100μm: 
Bead cross-sectional area = (.1(𝑐𝑐𝑐𝑐 )2 )2 𝑋𝑋 𝛱𝛱  
 
Number of beads to cover central rod = 𝑆𝑆𝑆𝑆𝑑𝑑𝑆𝑆𝐵𝐵𝑐𝑐𝐵𝐵  𝐵𝐵𝑑𝑑𝐵𝐵𝐵𝐵  𝑜𝑜𝑆𝑆  𝑑𝑑𝑜𝑜𝐵𝐵
𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵  𝑐𝑐𝑑𝑑𝑜𝑜𝑐𝑐𝑐𝑐 −𝑐𝑐𝐵𝐵𝑐𝑐𝑑𝑑𝑑𝑑𝑜𝑜𝑠𝑠𝐵𝐵𝑠𝑠  𝐵𝐵𝑑𝑑𝐵𝐵𝐵𝐵 =  43.7𝑐𝑐𝑐𝑐  𝑋𝑋 16𝑐𝑐𝑐𝑐  𝑋𝑋 𝛱𝛱 (.1(𝑐𝑐𝑐𝑐 )2 )2 𝑋𝑋 𝛱𝛱  =  
= 279,680 beads 
 
Settle bead volume = 279,680 𝑏𝑏𝐵𝐵𝐵𝐵𝐵𝐵𝑐𝑐1 𝑋𝑋 106 𝑏𝑏𝐵𝐵𝐵𝐵𝐵𝐵𝑐𝑐 /𝑐𝑐𝑠𝑠  ≈ .28ml Bioreactor Media Flow 
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Media flow was determined based on the Dynamax Peristaltic Pump User Manual 
by Rainin. Based on the type of tubing used, as well as the length and inner diameter, 
approximations could be drawn as to the strength of the fluid flow within the bioreactor. 
Based on the materials used in our design, the flow values were found based on the chart 
below.  
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Cost of Beads Materials 
 
Beads + Magnetic fluid 
  Material Quantity Cost ($) 
Lauric acid – Alfa 2.1g 0.05796 
Iron(II) Chloride Tetrahydrate – Alfa 4.77g 0.63918 
Iron(III) Chloride hexahydrate – Alfa 12.97g 1.395572 
Soybean Oil – Spectrum 175ml 8.640625 
Polysorbate 80 – JT Baker 5.4g 0.63828 
SeaKem LE Agarose – Lonza .3g 0.378 
   Bead Activation 
  Material Quantity Cost($) 
1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide .019g 0.10393 
N-hydroxysuccinimide .023g 0.02852 
   Collagen Coating 
  Material Quantity Cost ($) 
Collagen - Spectrum .1g 12 
Sodium Bicarbonate .01g 0.07587253 
Sodium Carbonate .01g 0.21645022 
   
 
Total: $24.17 
Approximate yield = 2ml of beads 
  
MQP Budget 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item Cost (in Dollars) 
Notebook 19 
Nylon Rod (.25") 4.6 
Nylon Rod (.112") 6.75 
Nylon Nuts (.25") 2.95 
Nylon Nuts (.112") 3.95 
Nylon Washers (.25") 1.32 
Dialysis Tubing (2) 11.7 
Magnets (.25) 36 
Magnets (.112) 21 
Teflon Tape 0.97 
Silicon Caulking 5.89 
Rubber Stoppers 5.5 
Soybean Oil 66.5 
Polysorbate 61.45 
Agarose 89.13 
Comercial Beads 70 
Silicon Tubing (50 ft) 30 
Total Spent 436.71 
Budget Remaining 30.29 
